PMID,Title,Authors,Citation,First Author,Journal/Book,Publication Year,Create Date,PMCID,NIHMS ID,DOI
"31222944","Oxycodone concentrations in the central nervous system and cerebrospinal fluid after epidural administration to the pregnant ewe","Kinnunen M, Kokki H, Hautajärvi H, Lantto J, Räsänen J, Voipio HM, Kokki M.","Basic Clin Pharmacol Toxicol. 2019 Nov;125(5):430-438. doi: 10.1111/bcpt.13276. Epub 2019 Jul 11.","Kinnunen M","Basic Clin Pharmacol Toxicol","2019","2019/06/22","","","10.1111/bcpt.13276"
"30571123","Synthesis, Biological, and Structural Explorations of New Zwitterionic Derivatives of 14- O-Methyloxymorphone, as Potent μ/δ Opioid Agonists and Peripherally Selective Antinociceptives","Spetea M, Rief SB, Haddou TB, Fink M, Kristeva E, Mittendorfer H, Haas S, Hummer N, Follia V, Guerrieri E, Asim MF, Sturm S, Schmidhammer H.","J Med Chem. 2019 Jan 24;62(2):641-653. doi: 10.1021/acs.jmedchem.8b01327. Epub 2019 Jan 3.","Spetea M","J Med Chem","2019","2018/12/21","PMC6348443","","10.1021/acs.jmedchem.8b01327"
"30448155","A large HCV transmission network enabled a fast-growing HIV outbreak in rural Indiana, 2015","Ramachandran S, Thai H, Forbi JC, Galang RR, Dimitrova Z, Xia GL, Lin Y, Punkova LT, Pontones PR, Gentry J, Blosser SJ, Lovchik J, Switzer WM, Teshale E, Peters P, Ward J, Khudyakov Y; Hepatitis C Investigation Team.","EBioMedicine. 2018 Nov;37:374-381. doi: 10.1016/j.ebiom.2018.10.007. Epub 2018 Nov 15.","Ramachandran S","EBioMedicine","2018","2018/11/19","PMC6284413","","10.1016/j.ebiom.2018.10.007"
"30391868","Positivity rates of drugs in patients treated for opioid dependence with buprenorphine: A comparison of oral fluid and urine using paired collections and LC-MS/MS","West R, Mikel C, Hofilena D, Guevara M.","Drug Alcohol Depend. 2018 Dec 1;193:183-191. doi: 10.1016/j.drugalcdep.2018.07.023. Epub 2018 Sep 1.","West R","Drug Alcohol Depend","2018","2018/11/05","","","10.1016/j.drugalcdep.2018.07.023"
"30189012","Pharmacokinetics of oxycodone/naloxone and its metabolites in patients with end-stage renal disease during and between haemodialysis sessions","Leuppi-Taegtmeyer A, Duthaler U, Hammann F, Schmid Y, Dickenmann M, Amico P, Jehle AW, Kalbermatter S, Lenherr C, Meyer Zu Schwabedissen HE, Haschke M, Liechti ME, Krähenbühl S.","Nephrol Dial Transplant. 2019 Apr 1;34(4):692-702. doi: 10.1093/ndt/gfy285.","Leuppi-Taegtmeyer A","Nephrol Dial Transplant","2019","2018/09/07","","","10.1093/ndt/gfy285"
"29766592","Scoring the best deal: Quantity discounts and street price variation of diverted oxycodone and oxymorphone","Lebin JA, Murphy DL, Severtson SG, Bau GE, Dasgupta N, Dart RC.","Pharmacoepidemiol Drug Saf. 2019 Jan;28(1):25-30. doi: 10.1002/pds.4558. Epub 2018 May 15.","Lebin JA","Pharmacoepidemiol Drug Saf","2019","2018/05/17","","","10.1002/pds.4558"
"29554298","Development of a Quantitative LC-MS-MS Assay for Codeine, Morphine, 6-Acetylmorphine, Hydrocodone, Hydromorphone, Oxycodone and Oxymorphone in Neat Oral Fluid","Grabenauer M, Moore KN, Bynum ND, White RM, Mitchell JM, Hayes ED, Flegel R.","J Anal Toxicol. 2018 Jul 1;42(6):392-399. doi: 10.1093/jat/bky021.","Grabenauer M","J Anal Toxicol","2018","2018/03/20","","","10.1093/jat/bky021"
"29414014","Determination of oxycodone and its major metabolites in haematic and urinary matrices: Comparison of traditional and miniaturised sampling approaches","Protti M, Catapano MC, Samolsky Dekel BG, Rudge J, Gerra G, Somaini L, Mandrioli R, Mercolini L.","J Pharm Biomed Anal. 2018 Apr 15;152:204-214. doi: 10.1016/j.jpba.2018.01.043. Epub 2018 Jan 31.","Protti M","J Pharm Biomed Anal","2018","2018/02/08","","","10.1016/j.jpba.2018.01.043"
"29314653","Identification of oxymorphone as decomposition product of the permitted drug methylnaltrexone","Sobolevsky T, Kucherova Y, Ahrens B.","Drug Test Anal. 2018 May;10(5):892-895. doi: 10.1002/dta.2353. Epub 2018 Feb 6.","Sobolevsky T","Drug Test Anal","2018","2018/01/10","","","10.1002/dta.2353"
"29308589","Abuse of reformulated OxyContin: Updated findings from a sentinel surveillance sample of individuals assessed for substance use disorder","Cassidy TA, Thorley E, Black RA, DeVeaugh-Geiss A, Butler SF, Coplan P.","J Opioid Manag. 2017 Nov/Dec;13(6):425-440. doi: 10.5055/jom.2017.0419.","Cassidy TA","J Opioid Manag","2017","2018/01/09","","","10.5055/jom.2017.0419"
"29278838","Multiple injections per injection episode: High-risk injection practice among people who injected pills during the 2015 HIV outbreak in Indiana","Broz D, Zibbell J, Foote C, Roseberry JC, Patel MR, Conrad C, Chapman E, Peters PJ, Needle R, McAlister C, Duwve JM.","Int J Drug Policy. 2018 Feb;52:97-101. doi: 10.1016/j.drugpo.2017.12.003. Epub 2017 Dec 24.","Broz D","Int J Drug Policy","2018","2017/12/27","","","10.1016/j.drugpo.2017.12.003"
"28814158","A Phase I study of the pharmacokinetics, safety and tolerability of a novel tocopheryl phosphate mixture/oxymorphone transdermal patch system","Gavin PD, Simon LS, Schlagheck T, Smith AJ, Krishnarajah J.","Pain Manag. 2017 Nov;7(6):499-512. doi: 10.2217/pmt-2017-0032. Epub 2017 Aug 17.","Gavin PD","Pain Manag","2017","2017/08/18","","","10.2217/pmt-2017-0032"
"28802086","Acute kidney injury is common with intravenous abuse of extended-release oral oxymorphone and delayed renal recovery rates are associated with increased KDIGO staging","Bonnecaze AK, Wilson MW, Dharod A, Fletcher A, Miller PJ.","Nephrology (Carlton). 2018 Oct;23(10):921-926. doi: 10.1111/nep.13153.","Bonnecaze AK","Nephrology (Carlton)","2018","2017/08/13","","","10.1111/nep.13153"
"28786851","Oxymorphone Hydrochloride Extended-Release (OPANA®) Associated With Acute Kidney Injury in a Chronic Pain Patient: A Case Report","Yatsynovich Y, Souza D, Maroz N.","A A Case Rep. 2017 Dec 1;9(11):324-327. doi: 10.1213/XAA.0000000000000607.","Yatsynovich Y","A A Case Rep","2017","2017/08/09","","","10.1213/XAA.0000000000000607"
"28718268","Oxymorphone Induced Thrombotic Microangiopathy Mimicking Atypical Haemolytic Uremic Syndrome","Gandhi A, Ullah S, Kotadia S, Nasser S.","J Ayub Med Coll Abbottabad. 2017 Apr-Jun;29(2):360-362.","Gandhi A","J Ayub Med Coll Abbottabad","2017","2017/07/19","","",""
"28716778","Thrombotic microangiopathy associated with intravenous injection of extended-release oxycodone","Robson KJ, Clucas D, Filshie R, Nandurkar H.","BMJ Case Rep. 2017 Jul 17;2017:bcr2017220977. doi: 10.1136/bcr-2017-220977.","Robson KJ","BMJ Case Rep","2017","2017/07/19","PMC5535099","","10.1136/bcr-2017-220977"
"28526155","Ketorolac, Oxymorphone, Tapentadol, and Tramadol: A Comprehensive Review","Vadivelu N, Chang D, Helander EM, Bordelon GJ, Kai A, Kaye AD, Hsu D, Bang D, Julka I.","Anesthesiol Clin. 2017 Jun;35(2):e1-e20. doi: 10.1016/j.anclin.2017.01.001. Epub 2017 Apr 14.","Vadivelu N","Anesthesiol Clin","2017","2017/05/21","","","10.1016/j.anclin.2017.01.001"
"28257549","Analysis of Intensive Care Unit Admission and Sequelae in Patients Intravenously Abusing Extended-Release Oral Oxymorphone","Wilson MW, Bonnecaze AK, Dharod A, Miller PJ.","South Med J. 2017 Mar;110(3):217-222. doi: 10.14423/SMJ.0000000000000624.","Wilson MW","South Med J","2017","2017/03/04","","","10.14423/SMJ.0000000000000624"
"28209752","Opana ER-induced thrombotic microangiopathy","Lämmle B.","Blood. 2017 Feb 16;129(7):808-809. doi: 10.1182/blood-2016-12-754507.","Lämmle B","Blood","2017","2017/02/18","","","10.1182/blood-2016-12-754507"
"28192197","Characterization of [(3)H] oxymorphone binding sites in mouse brain: Quantitative autoradiography in opioid receptor knockout mice","Yoo JH, Borsodi A, Tóth G, Benyhe S, Gaspar R, Matifas A, Kieffer BL, Metaxas A, Kitchen I, Bailey A.","Neurosci Lett. 2017 Mar 16;643:16-21. doi: 10.1016/j.neulet.2017.02.002. Epub 2017 Feb 10.","Yoo JH","Neurosci Lett","2017","2017/02/14","","","10.1016/j.neulet.2017.02.002"
"28080998","Determination of oxycodone and its major metabolites noroxycodone and oxymorphone by ultra-high-performance liquid chromatography tandem mass spectrometry in plasma and urine: application to real cases","Pantano F, Brauneis S, Forneris A, Pacifici R, Marinelli E, Kyriakou C, Pichini S, Busardò FP.","Clin Chem Lab Med. 2017 Aug 28;55(9):1324-1331. doi: 10.1515/cclm-2016-0990.","Pantano F","Clin Chem Lab Med","2017","2017/01/13","","","10.1515/cclm-2016-0990"
"28011222","Benzylideneoxymorphone: A new lead for development of bifunctional mu/delta opioid receptor ligands","Healy JR, Bezawada P, Griggs NW, Devereaux AL, Matsumoto RR, Traynor JR, Coop A, Cunningham CW.","Bioorg Med Chem Lett. 2017 Feb 1;27(3):666-669. doi: 10.1016/j.bmcl.2016.11.057. Epub 2016 Nov 22.","Healy JR","Bioorg Med Chem Lett","2017","2016/12/25","PMC5404377","NIHMS838405","10.1016/j.bmcl.2016.11.057"
"27864296","A mechanistic investigation of thrombotic microangiopathy associated with IV abuse of Opana ER","Hunt R, Yalamanoglu A, Tumlin J, Schiller T, Baek JH, Wu A, Fogo AB, Yang H, Wong E, Miller P, Buehler PW, Kimchi-Sarfaty C.","Blood. 2017 Feb 16;129(7):896-905. doi: 10.1182/blood-2016-08-736579. Epub 2016 Nov 18.","Hunt R","Blood","2017","2016/11/20","PMC5314814","","10.1182/blood-2016-08-736579"
"27764026","Suitability of the DRI Hydrocodone/Hydromorphone Immunoassay in the Clinical Environment at a Lower Cutoff: Validation With LC-MS/MS Analysis","Dixon RB, Dasgupta A.","Ther Drug Monit. 2016 Dec;38(6):787-790. doi: 10.1097/FTD.0000000000000339.","Dixon RB","Ther Drug Monit","2016","2016/10/21","","","10.1097/FTD.0000000000000339"
"27723230","Effect of morphine, methadone, hydromorphone or oxymorphone on the thermal threshold, following intravenous or buccal administration to cats","Pypendop BH, Shilo-Benjamini Y, Ilkiw JE.","Vet Anaesth Analg. 2016 Nov;43(6):635-642. doi: 10.1111/vaa.12356. Epub 2016 Mar 1.","Pypendop BH","Vet Anaesth Analg","2016","2016/10/11","","","10.1111/vaa.12356"
"27702939","Degradation of Opioids and Opiates During Acid Hydrolysis Leads to Reduced Recovery Compared to Enzymatic Hydrolysis","Sitasuwan P, Melendez C, Marinova M, Mastrianni KR, Darragh A, Ryan E, Lee LA.","J Anal Toxicol. 2016 Oct;40(8):601-607. doi: 10.1093/jat/bkw085.","Sitasuwan P","J Anal Toxicol","2016","2016/10/06","","","10.1093/jat/bkw085"
"27589376","Dialyzability of Oxycodone and Its Metabolites in Chronic Noncancer Pain Patients with End-Stage Renal Disease","Samolsky Dekel BG, Donati G, Vasarri A, Croci Chiocchini AL, Gori A, Cavallari G, Di Nino G, Mercolini L, Protti M, Mandrioli R, Melotti RM, La Manna G.","Pain Pract. 2017 Jun;17(5):604-615. doi: 10.1111/papr.12483. Epub 2016 Sep 2.","Samolsky Dekel BG","Pain Pract","2017","2016/09/03","","","10.1111/papr.12483"
"27487158","New Initiation of Long-Acting Opioids in Long-Stay Nursing Home Residents","Pimentel CB, Gurwitz JH, Tjia J, Hume AL, Lapane KL.","J Am Geriatr Soc. 2016 Sep;64(9):1772-8. doi: 10.1111/jgs.14306. Epub 2016 Aug 3.","Pimentel CB","J Am Geriatr Soc","2016","2016/08/04","PMC5040602","NIHMS781831","10.1111/jgs.14306"
"27468059","HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014-2015","Peters PJ, Pontones P, Hoover KW, Patel MR, Galang RR, Shields J, Blosser SJ, Spiller MW, Combs B, Switzer WM, Conrad C, Gentry J, Khudyakov Y, Waterhouse D, Owen SM, Chapman E, Roseberry JC, McCants V, Weidle PJ, Broz D, Samandari T, Mermin J, Walthall J, Brooks JT, Duwve JM; Indiana HIV Outbreak Investigation Team.","N Engl J Med. 2016 Jul 21;375(3):229-39. doi: 10.1056/NEJMoa1515195.","Peters PJ","N Engl J Med","2016","2016/07/29","","","10.1056/NEJMoa1515195"
"27405370","Prescription Opioids. V. Metabolism and Excretion of Oxymorphone in Urine Following Controlled Single Dose Administration","DePriest AZ, Heltsley R, Black DL, Mitchell JM, LoDico C, Flegel R, Cone EJ.","J Anal Toxicol. 2016 Oct;40(8):566-574. doi: 10.1093/jat/bkw064. Epub 2016 Jul 11.","DePriest AZ","J Anal Toxicol","2016","2016/07/14","","","10.1093/jat/bkw064"
"27405363","Case Report of Methylone, Oxymorphone and Ethanol in a Fatality Case with Tissue Distribution","Shimomura ET, Briones AJ, Warren WS, Addison JW, Knittel JL, Shoemaker SA, King TD, Bosy TZ.","J Anal Toxicol. 2016 Sep;40(7):543-5. doi: 10.1093/jat/bkw045. Epub 2016 Jul 11.","Shimomura ET","J Anal Toxicol","2016","2016/07/14","","","10.1093/jat/bkw045"
"27186712","A tale of 2 ADFs: differences in the effectiveness of abuse-deterrent formulations of oxymorphone and oxycodone extended-release drugs","Cicero TJ, Ellis MS, Kasper ZA.","Pain. 2016 Jun;157(6):1232-8. doi: 10.1097/j.pain.0000000000000511.","Cicero TJ","Pain","2016","2016/05/18","","","10.1097/j.pain.0000000000000511"
"27169165","THROMBOTIC MICROANGIOPATHY ASSOCIATED WITH OPANA ER INTRAVENOUS ABUSE A Case Report","Jabr FI, Yu L.","J Med Liban. 2016 Jan-Mar;64(1):40-2. doi: 10.12816/0023831.","Jabr FI","J Med Liban","2016","2016/05/13","","","10.12816/0023831"
"27052850","LC-MS-MS Method for Analysis of Opiates in Wastewater During Football Games II","Gul W, Stamper B, Godfrey M, Gul SW, ElSohly MA.","J Anal Toxicol. 2016 Jun;40(5):330-7. doi: 10.1093/jat/bkw022. Epub 2016 Apr 6.","Gul W","J Anal Toxicol","2016","2016/04/08","","","10.1093/jat/bkw022"
"26719075","Abuse-Deterrent Opioid Formulations: Pharmacokinetic and Pharmacodynamic Considerations","Walter C, Knothe C, Lötsch J.","Clin Pharmacokinet. 2016 Jul;55(7):751-767. doi: 10.1007/s40262-015-0362-3.","Walter C","Clin Pharmacokinet","2016","2016/01/01","","","10.1007/s40262-015-0362-3"
"26655109","Development of a sensitive method for the determination of oxycodone and its major metabolites noroxycodone and oxymorphone in human plasma by liquid chromatography-tandem mass spectrometry","Gaudette F, Sirhan-Daneau A, St-Onge M, Turgeon J, Michaud V.","J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Jan 1;1008:174-180. doi: 10.1016/j.jchromb.2015.11.035. Epub 2015 Nov 23.","Gaudette F","J Chromatogr B Analyt Technol Biomed Life Sci","2016","2015/12/15","","","10.1016/j.jchromb.2015.11.035"
"26437280","Opioid associated intravenous and cutaneous microvascular drug abuse (skin-popping) masquerading as Degos disease (malignant atrophic papulosis) with multiorgan involvement","Magro CM, Toledo-Garcia A, Pala O, Momtahen S, Shapiro L.","Dermatol Online J. 2015 Sep 17;21(9):13030/qt7dk8q7n1.","Magro CM","Dermatol Online J","2015","2015/10/06","","",""
"26304250","Commentary","Garg M, Davis L.","Ann Emerg Med. 2015 Sep;66(3):316-7. doi: 10.1016/j.annemergmed.2015.05.032.","Garg M","Ann Emerg Med","2015","2015/08/26","","","10.1016/j.annemergmed.2015.05.032"
"26178162","The Disposition of Oxycodone and Metabolite in Human Hair","Reisfield GM, Jones JT.","J Anal Toxicol. 2015 Nov-Dec;39(9):746-50. doi: 10.1093/jat/bkv076. Epub 2015 Jul 14.","Reisfield GM","J Anal Toxicol","2015","2015/07/17","","","10.1093/jat/bkv076"
"26122463","Species-specific lipophilicity of morphine antagonists","Mazák K, Hosztafi S, Noszál B.","Eur J Pharm Sci. 2015 Oct 12;78:1-7. doi: 10.1016/j.ejps.2015.06.026. Epub 2015 Jun 26.","Mazák K","Eur J Pharm Sci","2015","2015/07/01","","","10.1016/j.ejps.2015.06.026"
"26112082","Acute Sensorineural Hearing Loss After Abuse of an Inhaled, Crushed Oxymorphone Extended-Release Tablet","MacDonald LE, Onsrud JE, Mullins-Hodgin R.","Pharmacotherapy. 2015 Jul;35(7):e118-21. doi: 10.1002/phar.1605. Epub 2015 Jun 25.","MacDonald LE","Pharmacotherapy","2015","2015/06/27","","","10.1002/phar.1605"
"26111087","Effects of oxymorphone hydrochloride or hydromorphone hydrochloride on minimal alveolar concentration of desflurane in sheep","Sayre RS, Lepiz MA, Horsley KT, Pashmakova MB, Barr JW, Washburn SE.","Am J Vet Res. 2015 Jul;76(7):583-90. doi: 10.2460/ajvr.76.7.583.","Sayre RS","Am J Vet Res","2015","2015/06/26","","","10.2460/ajvr.76.7.583"
"26095066","A case of rhabdomyolysis associated with severe opioid withdrawal","Gangahar D.","Am J Addict. 2015 Aug;24(5):400-2. doi: 10.1111/ajad.12255. Epub 2015 Jun 22.","Gangahar D","Am J Addict","2015","2015/06/23","","","10.1111/ajad.12255"
"25928470","Community Outbreak of HIV Infection Linked to Injection Drug Use of Oxymorphone--Indiana, 2015","Conrad C, Bradley HM, Broz D, Buddha S, Chapman EL, Galang RR, Hillman D, Hon J, Hoover KW, Patel MR, Perez A, Peters PJ, Pontones P, Roseberry JC, Sandoval M, Shields J, Walthall J, Waterhouse D, Weidle PJ, Wu H, Duwve JM; Centers for Disease Control and Prevention (CDC).","MMWR Morb Mortal Wkly Rep. 2015 May 1;64(16):443-4.","Conrad C","MMWR Morb Mortal Wkly Rep","2015","2015/05/01","PMC4584812","",""
"25816813","Indiana declares health emergency in response to HIV outbreak","McCarthy M.","BMJ. 2015 Mar 27;350:h1708. doi: 10.1136/bmj.h1708.","McCarthy M","BMJ","2015","2015/03/31","","","10.1136/bmj.h1708"
"25705958","A Randomized, Double-blind, Placebo-Controlled Crossover Trial of Oxymorphone Hydrochloride and Propoxyphene/Acetaminophen Combination for the Treatment of Neurogenic Claudication Associated With Lumbar Spinal Stenosis","Markman JD, Gewandter JS, Frazer ME, Murray NM, Rast SA, McDermott MP, Chowdhry AK, Tomkinson EJ, Pilcher WH, Walter KA, Dworkin RH.","Spine (Phila Pa 1976). 2015 May 15;40(10):684-91. doi: 10.1097/BRS.0000000000000837.","Markman JD","Spine (Phila Pa 1976)","2015","2015/02/24","","","10.1097/BRS.0000000000000837"
"25503691","[Long-term opioid therapy in chronic noncancer pain. A systematic review and meta-analysis of efficacy, tolerability and safety in open-label extension trials with study duration of at least 26 weeks]","Häuser W, Bernardy K, Maier C.","Schmerz. 2015 Feb;29(1):96-108. doi: 10.1007/s00482-014-1452-0.","Häuser W","Schmerz","2015","2014/12/16","","","10.1007/s00482-014-1452-0"
"25288721","Urine drug testing for oxycodone and its metabolites as a tool for drug-drug interactions?","Mikus G.","J Anal Toxicol. 2015 Jan-Feb;39(1):81-2. doi: 10.1093/jat/bku111. Epub 2014 Oct 6.","Mikus G","J Anal Toxicol","2015","2014/10/08","","","10.1093/jat/bku111"
"25288719","Response to urine drug testing for oxycodone and its metabolites as a tool for drug-drug interactions","Elder NM, Atayee RS, Best BM, Ma JD.","J Anal Toxicol. 2015 Jan-Feb;39(1):80. doi: 10.1093/jat/bku112. Epub 2014 Oct 6.","Elder NM","J Anal Toxicol","2015","2014/10/08","","","10.1093/jat/bku112"
"25217546","Case management in a DUI lab: effect on drugs reported","Tiscione NB, Shan X, Yeatman DT.","J Anal Toxicol. 2014 Oct;38(8):555-8. doi: 10.1093/jat/bku076.","Tiscione NB","J Anal Toxicol","2014","2014/09/14","","","10.1093/jat/bku076"
"25217537","Multi-drug and metabolite quantification in postmortem blood by liquid chromatography-high-resolution mass spectrometry: comparison with nominal mass technology","Rosano TG, Na S, Ihenetu K, Swift TA, Wood M.","J Anal Toxicol. 2014 Oct;38(8):495-506. doi: 10.1093/jat/bku066.","Rosano TG","J Anal Toxicol","2014","2014/09/14","","","10.1093/jat/bku066"
"25130052","Pharmacodynamic effects of oral oxymorphone: abuse liability, analgesic profile and direct physiologic effects in humans","Babalonis S, Lofwall MR, Nuzzo PA, Walsh SL.","Addict Biol. 2016 Jan;21(1):146-58. doi: 10.1111/adb.12173. Epub 2014 Jul 31.","Babalonis S","Addict Biol","2016","2014/08/19","PMC4383736","NIHMS673036","10.1111/adb.12173"
"25121773","Effects of aprepitant on the pharmacokinetics of controlled-release oral oxycodone in cancer patients","Fujiwara Y, Toyoda M, Chayahara N, Kiyota N, Shimada T, Imamura Y, Mukohara T, Minami H.","PLoS One. 2014 Aug 14;9(8):e104215. doi: 10.1371/journal.pone.0104215. eCollection 2014.","Fujiwara Y","PLoS One","2014","2014/08/15","PMC4133207","","10.1371/journal.pone.0104215"
"25002456","Unauthorized drug use in the US Army based on medical review officer evaluations","Platteborze PL, Kippenberger DJ, Martin TM.","J Anal Toxicol. 2014 Nov-Dec;38(9):653-9. doi: 10.1093/jat/bku079. Epub 2014 Jul 6.","Platteborze PL","J Anal Toxicol","2014","2014/07/09","","","10.1093/jat/bku079"
"24986838","Authors' reply","Elder NM, Atayee RS, Best BM, Ma JD.","J Anal Toxicol. 2014 Sep;38(7):463. doi: 10.1093/jat/bku074. Epub 2014 Jul 1.","Elder NM","J Anal Toxicol","2014","2014/07/03","","","10.1093/jat/bku074"
"24986837","Uncertainty in assessing impact of drug-drug interactions on oxycodone metabolite patterns","DePriest AZ, Puet BL, Heltsley R, Robert T, Black DL.","J Anal Toxicol. 2014 Sep;38(7):462. doi: 10.1093/jat/bku071. Epub 2014 Jul 1.","DePriest AZ","J Anal Toxicol","2014","2014/07/03","","","10.1093/jat/bku071"
"24921173","Diffuse retinal ischemia following intravenous crushed oxymorphone abuse","Shah RJ, Cherney EF.","JAMA Ophthalmol. 2014 Jun;132(6):780-1. doi: 10.1001/jamaophthalmol.2014.324.","Shah RJ","JAMA Ophthalmol","2014","2014/06/13","","","10.1001/jamaophthalmol.2014.324"
"24919067","Pharmacological investigations of N-substituent variation in morphine and oxymorphone: opioid receptor binding, signaling and antinociceptive activity","Ben Haddou T, Béni S, Hosztafi S, Malfacini D, Calo G, Schmidhammer H, Spetea M.","PLoS One. 2014 Jun 11;9(6):e99231. doi: 10.1371/journal.pone.0099231. eCollection 2014.","Ben Haddou T","PLoS One","2014","2014/06/12","PMC4053365","","10.1371/journal.pone.0099231"
"24914505","Can Chronic Pain Patients Be Adequately Treated Using Generic Pain Medications to the Exclusion of Brand-Name Ones?","Candido KD, Chiweshe J, Anantamongkol U, Knezevic NN.","Am J Ther. 2016 Mar-Apr;23(2):e489-97. doi: 10.1097/MJT.0000000000000098.","Candido KD","Am J Ther","2016","2014/06/11","","","10.1097/MJT.0000000000000098"
"24905321","Pharmacokinetics of oxycodone hydrochloride and three of its metabolites after intravenous administration in Chinese patients with pain","Hao GT, Zhou HY, Gao HZ, Qu HY, Liang YG, Li YY, Dong RH, Zhang LJ, Wang XF, Liu ZY.","Pharmacol Rep. 2014 Feb;66(1):153-8. doi: 10.1016/j.pharep.2013.08.012. Epub 2014 Feb 1.","Hao GT","Pharmacol Rep","2014","2014/06/07","","","10.1016/j.pharep.2013.08.012"
"24738694","Use of prescription opioids with abuse-deterrent technology to address opioid abuse","Michna E, Kirson NY, Shei A, Birnbaum HG, Ben-Joseph R.","Curr Med Res Opin. 2014 Aug;30(8):1589-98. doi: 10.1185/03007995.2014.915803. Epub 2014 Apr 24.","Michna E","Curr Med Res Opin","2014","2014/04/18","","","10.1185/03007995.2014.915803"
"24668845","Successful treatment of intravenously abused oral Opana ER-induced thrombotic microangiopathy without plasma exchange","Miller PJ, Farland AM, Knovich MA, Batt KM, Owen J.","Am J Hematol. 2014 Jul;89(7):695-7. doi: 10.1002/ajh.23720. Epub 2014 Apr 15.","Miller PJ","Am J Hematol","2014","2014/03/27","","","10.1002/ajh.23720"
"24630802","Resurgence of intravenous Opana as a cause of secondary thrombotic thrombocytopenic purpura","Rane M, Aggarwal A, Banas E, Sharma A.","Am J Emerg Med. 2014 Aug;32(8):951.e3-4. doi: 10.1016/j.ajem.2014.01.058. Epub 2014 Feb 7.","Rane M","Am J Emerg Med","2014","2014/03/18","","","10.1016/j.ajem.2014.01.058"
"24604569","Monitoring oxycodone use in patients with chronic pain: analysis of oxycodone and metabolite excretion in saliva and urine","Moy KV, Ma JD, Morello CM, Atayee RS, Best BM.","J Opioid Manag. 2014 Jan-Feb;10(1):47-56. doi: 10.5055/jom.2014.0191.","Moy KV","J Opioid Manag","2014","2014/03/08","","","10.5055/jom.2014.0191"
"24591390","Opana ER abuse and thrombotic thrombocytopenic purpura (TTP)-like illness: a rising risk factor in illicit drug users","Kapila A, Chhabra L, Chaubey VK, Summers J.","BMJ Case Rep. 2014 Mar 3;2014:bcr2013203122. doi: 10.1136/bcr-2013-203122.","Kapila A","BMJ Case Rep","2014","2014/03/05","PMC3947999","","10.1136/bcr-2013-203122"
"24564308","Comparison of the cardiorespiratory effects of a combination of ketamine and propofol, propofol alone, or a combination of ketamine and diazepam before and after induction of anesthesia in dogs sedated with acepromazine and oxymorphone","Henao-Guerrero N, Riccó CH.","Am J Vet Res. 2014 Mar;75(3):231-9. doi: 10.2460/ajvr.75.3.231.","Henao-Guerrero N","Am J Vet Res","2014","2014/02/26","","","10.2460/ajvr.75.3.231"
"24529995","Thrombotic microangiopathy and acute kidney injury associated with intravenous abuse of an oral extended-release formulation of oxymorphone hydrochloride: kidney biopsy findings and report of 3 cases","Ambruzs JM, Serrell PB, Rahim N, Larsen CP.","Am J Kidney Dis. 2014 Jun;63(6):1022-6. doi: 10.1053/j.ajkd.2014.01.015. Epub 2014 Feb 14.","Ambruzs JM","Am J Kidney Dis","2014","2014/02/18","","","10.1053/j.ajkd.2014.01.015"
"24523296","Observations of urinary oxycodone and metabolite distributions in pain patients","Elder NM, Atayee RS, Best BM, Ma JD.","J Anal Toxicol. 2014 Apr;38(3):129-34. doi: 10.1093/jat/bku007. Epub 2014 Feb 11.","Elder NM","J Anal Toxicol","2014","2014/02/14","","","10.1093/jat/bku007"
"24481932","Clinical applications of oxymorphone","Vadivelu N, Maria M, Jolly S, Rosenbloom J, Prasad A, Kaye AD.","J Opioid Manag. 2013 Nov-Dec;9(6):439-52. doi: 10.5055/jom.2013.0186.","Vadivelu N","J Opioid Manag","2013","2014/02/01","","","10.5055/jom.2013.0186"
"24369032","Opana-ER used the wrong way: intravenous abuse leading to microangiopathic hemolysis and a TTP-like syndrome","Amjad AI, Parikh RA.","Blood. 2013 Nov 14;122(20):3403. doi: 10.1182/blood-2013-05-503904.","Amjad AI","Blood","2013","2013/12/26","","","10.1182/blood-2013-05-503904"
"24344787","The safety and effectiveness of a long-acting transdermal fentanyl solution compared with oxymorphone for the control of postoperative pain in dogs: a randomized, multicentered clinical study","Martinez SA, Wilson MG, Linton DD, Newbound GC, Freise KJ, Lin TL, Clark TP.","J Vet Pharmacol Ther. 2014 Aug;37(4):394-405. doi: 10.1111/jvp.12096. Epub 2013 Dec 18.","Martinez SA","J Vet Pharmacol Ther","2014","2013/12/19","PMC4265281","","10.1111/jvp.12096"
"24330343","A randomized, rater-blinded, crossover study of the effects of oxymorphone extended release, fed versus fasting, on cognitive performance as tested with CANTAB in opioid-tolerant subjects","Spierings EL, Volkerts ER, Heitland I, Thomson H.","Pain Med. 2014 Feb;15(2):264-71. doi: 10.1111/pme.12307. Epub 2013 Dec 11.","Spierings EL","Pain Med","2014","2013/12/17","","","10.1111/pme.12307"
"24330279","Changes in prevalence of prescription opioid abuse after introduction of an abuse-deterrent opioid formulation","Cassidy TA, DasMahapatra P, Black RA, Wieman MS, Butler SF.","Pain Med. 2014 Mar;15(3):440-51. doi: 10.1111/pme.12295. Epub 2013 Dec 11.","Cassidy TA","Pain Med","2014","2013/12/17","","","10.1111/pme.12295"
"24236993","Bioavailability of morphine, methadone, hydromorphone, and oxymorphone following buccal administration in cats","Pypendop BH, Ilkiw JE, Shilo-Benjamini Y.","J Vet Pharmacol Ther. 2014 Jun;37(3):295-300. doi: 10.1111/jvp.12090. Epub 2013 Nov 18.","Pypendop BH","J Vet Pharmacol Ther","2014","2013/11/19","","","10.1111/jvp.12090"
"23980120","Validation of blood and liver oxymorphone analysis using LC-MS-MS: concentrations in 30 fatal overdoses","Crum ED, Bailey KM, Richards-Waugh LL, Clay DJ, Gebhardt MA, Kraner JC.","J Anal Toxicol. 2013 Oct;37(8):512-6. doi: 10.1093/jat/bkt077. Epub 2013 Aug 26.","Crum ED","J Anal Toxicol","2013","2013/08/28","","","10.1093/jat/bkt077"
"23743505","Determination of oxycodone, noroxycodone and oxymorphone by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry in human matrices: in vivo and in vitro applications","Fang WB, Lofwall MR, Walsh SL, Moody DE.","J Anal Toxicol. 2013 Jul-Aug;37(6):337-44. doi: 10.1093/jat/bkt042. Epub 2013 Jun 5.","Fang WB","J Anal Toxicol","2013","2013/06/08","PMC3708716","","10.1093/jat/bkt042"
"23733622","Cancer cachexia raises the plasma concentration of oxymorphone through the reduction of CYP3A but not CYP2D6 in oxycodone-treated patients","Naito T, Tashiro M, Ishida T, Ohnishi K, Kawakami J.","J Clin Pharmacol. 2013 Aug;53(8):812-8. doi: 10.1002/jcph.112. Epub 2013 Jun 3.","Naito T","J Clin Pharmacol","2013","2013/06/05","","","10.1002/jcph.112"
"23711948","Resolution of an apparent hook effect in Roche partner DRI oxycodone immunoassay","Colón-Franco JM, Cox ET, Crosby DB, Dawling S.","J Anal Toxicol. 2013 Jul-Aug;37(6):376-81. doi: 10.1093/jat/bkt044. Epub 2013 May 27.","Colón-Franco JM","J Anal Toxicol","2013","2013/05/29","","","10.1093/jat/bkt044"
"23609023","Prescription opioids. I. Metabolism and excretion patterns of oxycodone in urine following controlled single dose administration","Cone EJ, Heltsley R, Black DL, Mitchell JM, Lodico CP, Flegel RR.","J Anal Toxicol. 2013 Jun;37(5):255-64. doi: 10.1093/jat/bkt031. Epub 2013 Apr 21.","Cone EJ","J Anal Toxicol","2013","2013/04/24","","","10.1093/jat/bkt031"
"23601353","Pharmacokinetics of ammonium sulfate gradient loaded liposome-encapsulated oxymorphone and hydromorphone in healthy dogs","Smith LJ, Kukanich BK, Krugner-Higby LA, Schmidt BH, Heath TD.","Vet Anaesth Analg. 2013 Sep;40(5):537-45. doi: 10.1111/vaa.12042. Epub 2013 Apr 20.","Smith LJ","Vet Anaesth Analg","2013","2013/04/23","PMC3740050","NIHMS464878","10.1111/vaa.12042"
"23555934","CYP2D6 genotype dependent oxycodone metabolism in postoperative patients","Stamer UM, Zhang L, Book M, Lehmann LE, Stuber F, Musshoff F.","PLoS One. 2013;8(3):e60239. doi: 10.1371/journal.pone.0060239. Epub 2013 Mar 28.","Stamer UM","PLoS One","2013","2013/04/05","PMC3610662","","10.1371/journal.pone.0060239"
"23488585","Contribution of oxycodone and its metabolites to the overall analgesic effect after oxycodone administration","Klimas R, Witticke D, El Fallah S, Mikus G.","Expert Opin Drug Metab Toxicol. 2013 May;9(5):517-28. doi: 10.1517/17425255.2013.779669. Epub 2013 Mar 14.","Klimas R","Expert Opin Drug Metab Toxicol","2013","2013/03/16","","","10.1517/17425255.2013.779669"
"23463542","Oxymorphone active uptake at the blood-brain barrier and population modeling of its pharmacokinetic-pharmacodynamic relationship","Sadiq MW, Boström E, Keizer R, Björkman S, Hammarlund-Udenaes M.","J Pharm Sci. 2013 Sep;102(9):3320-31. doi: 10.1002/jps.23492. Epub 2013 Mar 5.","Sadiq MW","J Pharm Sci","2013","2013/03/07","","","10.1002/jps.23492"
"23435934","Oxymorphone insufflation associated with acute sensorineural hearing loss: case files of the University of Massachusetts medical toxicology fellowship","Boyle KL, Rosenbaum CD.","J Med Toxicol. 2013 Jun;9(2):179-83. doi: 10.1007/s13181-013-0293-z.","Boyle KL","J Med Toxicol","2013","2013/02/26","PMC3657028","","10.1007/s13181-013-0293-z"
"23375512","Single vs composite measures of pain intensity: relative sensitivity for detecting treatment effects","Jensen MP, Hu X, Potts SL, Gould EM.","Pain. 2013 Apr;154(4):534-8. doi: 10.1016/j.pain.2012.12.017. Epub 2012 Dec 28.","Jensen MP","Pain","2013","2013/02/05","","","10.1016/j.pain.2012.12.017"
"23302815","Thrombotic thrombocytopenic purpura (TTP)-like illness associated with intravenous Opana ER abuse--Tennessee, 2012","Centers for Disease Control and Prevention (CDC).","MMWR Morb Mortal Wkly Rep. 2013 Jan 11;62(1):1-4.","Centers for Disease Control and Prevention (CDC)","MMWR Morb Mortal Wkly Rep","2013","2013/01/11","PMC4604918","",""
"23264316","An open-label pharmacokinetic study of oxymorphone extended release in the presence of naltrexone in the older adult","Pergolizzi JV Jr, Raffa RB, Taylor R Jr, Nagar S, Labhsetwar S, Sinclair N, Gould EM.","J Opioid Manag. 2012 Nov-Dec;8(6):383-93. doi: 10.5055/jom.2012.0138.","Pergolizzi JV Jr","J Opioid Manag","2012","2012/12/25","","","10.5055/jom.2012.0138"
"23095430","The implications of tamper-resistant formulations for opioid rotation","Pappagallo M, Sokolowska M.","Postgrad Med. 2012 Sep;124(5):101-9. doi: 10.3810/pgm.2012.09.2588.","Pappagallo M","Postgrad Med","2012","2012/10/26","","","10.3810/pgm.2012.09.2588"
"23042473","The meaning of global outcome measures in pain clinical trials: more than just change in pain intensity","Jensen MP, Wang W, Potts SL, Gould EM.","Clin J Pain. 2013 Apr;29(4):289-95. doi: 10.1097/AJP.0b013e3182527b74.","Jensen MP","Clin J Pain","2013","2012/10/09","","","10.1097/AJP.0b013e3182527b74"
"22866355","Bilateral globus pallidus lesions","Alquist CR, McGoey R, Bastian F, Newman W 3rd.","J La State Med Soc. 2012 May-Jun;164(3):145-6.","Alquist CR","J La State Med Soc","2012","2012/08/08","","",""
"22795571","Simultaneous determination of oxymorphone and its active metabolite 6-OH-oxymorphone in human plasma by high performance liquid chromatography-tandem mass spectrometry","Zha W, Shum L.","J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Aug 1;902:116-21. doi: 10.1016/j.jchromb.2012.06.035. Epub 2012 Jul 1.","Zha W","J Chromatogr B Analyt Technol Biomed Life Sci","2012","2012/07/17","","","10.1016/j.jchromb.2012.06.035"
"22721679","Assessment of a formulation designed to be crush-resistant in prescription opioid abusers","Vosburg SK, Jones JD, Manubay JM, Ashworth JB, Benedek IH, Comer SD.","Drug Alcohol Depend. 2012 Nov 1;126(1-2):206-15. doi: 10.1016/j.drugalcdep.2012.05.013. Epub 2012 Jun 20.","Vosburg SK","Drug Alcohol Depend","2012","2012/06/23","PMC3654549","NIHMS463155","10.1016/j.drugalcdep.2012.05.013"
"22690792","Opioid extended-release tablets with improved tamper-resistant properties","Bartholomaeus JH, Arkenau-Marić E, Galia E.","Expert Opin Drug Deliv. 2012 Aug;9(8):879-91. doi: 10.1517/17425247.2012.698606. Epub 2012 Jun 13.","Bartholomaeus JH","Expert Opin Drug Deliv","2012","2012/06/14","","","10.1517/17425247.2012.698606"
"22511697","Observations on the urine metabolic ratio of oxymorphone to oxycodone in pain patients","Yee DA, Best BM, Atayee RS, Pesce AJ.","J Anal Toxicol. 2012 May;36(4):232-8. doi: 10.1093/jat/bks022.","Yee DA","J Anal Toxicol","2012","2012/04/19","","","10.1093/jat/bks022"
"22455592","Recent advances in the development of 14-alkoxy substituted morphinans as potent and safer opioid analgesics","Spetea M, Schmidhammer H.","Curr Med Chem. 2012;19(15):2442-57. doi: 10.2174/092986712800269308.","Spetea M","Curr Med Chem","2012","2012/03/30","","","10.2174/092986712800269308"
"22437221","Tolerability of concomitant use of selective serotonin reuptake inhibitors or serotonin-norepinephrine reuptake inhibitors and oxymorphone extended release","Peniston JH, Hu X, Potts SL, Wieman MS, Turk DC.","Postgrad Med. 2012 Mar;124(2):114-22. doi: 10.3810/pgm.2012.03.2542.","Peniston JH","Postgrad Med","2012","2012/03/23","","","10.3810/pgm.2012.03.2542"
"22208805","The effects of ethanol on the bioavailability of oxymorphone extended-release tablets and oxymorphone crush-resistant extended-release tablets","Fiske WD, Jobes J, Xiang Q, Chang SC, Benedek IH.","J Pain. 2012 Jan;13(1):90-9. doi: 10.1016/j.jpain.2011.10.011.","Fiske WD","J Pain","2012","2012/01/03","","","10.1016/j.jpain.2011.10.011"
"22162639","Bioequivalence of oxymorphone extended release and crush-resistant oxymorphone extended release","Benedek IH, Jobes J, Xiang Q, Fiske WD.","Drug Des Devel Ther. 2011;5:455-63. doi: 10.2147/DDDT.S24372. Epub 2011 Nov 23.","Benedek IH","Drug Des Devel Ther","2011","2011/12/14","PMC3232172","","10.2147/DDDT.S24372"
"22136049","Hydrophilic interaction LC-MS/MS analysis of opioids in urine: significance of glucuronide metabolites","French D, Wu A, Lynch K.","Bioanalysis. 2011 Dec;3(23):2603-12. doi: 10.4155/bio.11.266.","French D","Bioanalysis","2011","2011/12/06","","","10.4155/bio.11.266"
"22032675","Direct and indirect costs of patients treated with extended-release oxymorphone HCl or controlled-release oxycodone HCl","Kirson NY, White AG, Birnbaum HG, Schiller M, Waldman T, Peterson K, Ben-Joseph RH, Berner T, Summers KH.","J Med Econ. 2012;15(1):87-95. doi: 10.3111/13696998.2011.629261. Epub 2011 Oct 28.","Kirson NY","J Med Econ","2012","2011/10/29","","","10.3111/13696998.2011.629261"
"21823549","Positive and negative subjective effects of extended-release oxymorphone versus controlled-release oxycodone in recreational opioid users","Schoedel KA, McMorn S, Chakraborty B, Potts SL, Zerbe K, Sellers EM.","J Opioid Manag. 2011 May-Jun;7(3):179-92. doi: 10.5055/jom.2011.0061.","Schoedel KA","J Opioid Manag","2011","2011/08/10","","","10.5055/jom.2011.0061"
"21819798","An overdose death involving the insufflation of extended-release oxymorphone tablets","Vorce SP, Levine B, McDonough PC, Past MR.","J Anal Toxicol. 2010 Oct;34(8):521-6. doi: 10.1093/jat/34.8.521.","Vorce SP","J Anal Toxicol","2010","2011/08/09","","","10.1093/jat/34.8.521"
"21735164","Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study","Andreassen TN, Eftedal I, Klepstad P, Davies A, Bjordal K, Lundström S, Kaasa S, Dale O.","Eur J Clin Pharmacol. 2012 Jan;68(1):55-64. doi: 10.1007/s00228-011-1093-5. Epub 2011 Jul 7.","Andreassen TN","Eur J Clin Pharmacol","2012","2011/07/08","PMC3249195","","10.1007/s00228-011-1093-5"
"21657806","A comparison of daily average consumption (DACON) of oxycodone and oxymorphone long-acting oral tablets","Rubino M, Summers KH, Puenpatom A, Fu C, Ohsfeldt RL, Ben-Joseph RH.","J Manag Care Pharm. 2011 Jun;17(5):367-76. doi: 10.18553/jmcp.2011.17.5.367.","Rubino M","J Manag Care Pharm","2011","2011/06/11","","","10.18553/jmcp.2011.17.5.367"
"21621410","Generation of novel radiolabeled opiates through site-selective iodination","Majumdar S, Burgman M, Haselton N, Grinnell S, Ocampo J, Pasternak AR, Pasternak GW.","Bioorg Med Chem Lett. 2011 Jul 1;21(13):4001-4. doi: 10.1016/j.bmcl.2011.05.008. Epub 2011 May 8.","Majumdar S","Bioorg Med Chem Lett","2011","2011/05/31","PMC3115495","NIHMS295454","10.1016/j.bmcl.2011.05.008"
"21535013","Effect of amantadine on oxymorphone-induced thermal antinociception in cats","Siao KT, Pypendop BH, Escobar A, Stanley SD, Ilkiw JE.","J Vet Pharmacol Ther. 2012 Apr;35(2):169-74. doi: 10.1111/j.1365-2885.2011.01305.x. Epub 2011 Apr 28.","Siao KT","J Vet Pharmacol Ther","2012","2011/05/04","","","10.1111/j.1365-2885.2011.01305.x"
"21439215","Pharmacokinetics of oxymorphone in titi monkeys (Callicebus spp.) and rhesus macaques (Macaca mulatta)","Kelly KR, Pypendop BH, Grayson JK, Stanley SD, Christe KL, Summers LM, Lerche NW.","J Am Assoc Lab Anim Sci. 2011 Mar;50(2):212-20.","Kelly KR","J Am Assoc Lab Anim Sci","2011","2011/03/29","PMC3061422","",""
"21396229","Quantitation of opioids in whole blood by electron impact-gas chromatography-mass spectrometry","Tiscione NB, Shan X, Alford I, Yeatman DT.","J Anal Toxicol. 2011 Mar;35(2):99-107. doi: 10.1093/anatox/35.2.99.","Tiscione NB","J Anal Toxicol","2011","2011/03/15","","","10.1093/anatox/35.2.99"
"21323677","Pharmacokinetics of oxymorphone in cats","Siao KT, Pypendop BH, Stanley SD, Ilkiw JE.","J Vet Pharmacol Ther. 2011 Dec;34(6):594-8. doi: 10.1111/j.1365-2885.2011.01271.x. Epub 2011 Feb 16.","Siao KT","J Vet Pharmacol Ther","2011","2011/02/18","","","10.1111/j.1365-2885.2011.01271.x"
"21267044","Feasibility study of rapid opioid rotation and titration","Korkmazsky M, Ghandehari J, Sanchez A, Lin HM, Pappagallo M.","Pain Physician. 2011 Jan-Feb;14(1):71-82.","Korkmazsky M","Pain Physician","2011","2011/01/27","PMC3197741","NIHMS283902",""
"21209234","CYP3A5*3 affects plasma disposition of noroxycodone and dose escalation in cancer patients receiving oxycodone","Naito T, Takashina Y, Yamamoto K, Tashiro M, Ohnishi K, Kagawa Y, Kawakami J.","J Clin Pharmacol. 2011 Nov;51(11):1529-38. doi: 10.1177/0091270010388033. Epub 2011 Jan 5.","Naito T","J Clin Pharmacol","2011","2011/01/07","","","10.1177/0091270010388033"
"21174486","Elimination of intravenous oxycodone in the elderly: a pharmacokinetic study in postoperative orthopaedic patients of different age groups","Liukas A, Kuusniemi K, Aantaa R, Virolainen P, Neuvonen M, Neuvonen PJ, Olkkola KT.","Drugs Aging. 2011 Jan 1;28(1):41-50. doi: 10.2165/11586140-000000000-00000.","Liukas A","Drugs Aging","2011","2010/12/23","","","10.2165/11586140-000000000-00000"
"21140139","Influences on the pharmacokinetics of oxycodone: a multicentre cross-sectional study in 439 adult cancer patients","Andreassen TN, Klepstad P, Davies A, Bjordal K, Lundström S, Kaasa S, Dale O.","Eur J Clin Pharmacol. 2011 May;67(5):493-506. doi: 10.1007/s00228-010-0948-5. Epub 2010 Dec 8.","Andreassen TN","Eur J Clin Pharmacol","2011","2010/12/09","PMC3076582","","10.1007/s00228-010-0948-5"
"21102969","Reduced cognitive and psychomotor impairment with extended-release oxymorphone versus controlled-release oxycodone","Schoedel KA, McMorn S, Chakraborty B, Zerbe K, Sellers EM.","Pain Physician. 2010 Nov-Dec;13(6):561-73.","Schoedel KA","Pain Physician","2010","2010/11/25","","",""
"20857093","Effect of the inhibition of CYP3A4 or CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone","Kummer O, Hammann F, Moser C, Schaller O, Drewe J, Krähenbühl S.","Eur J Clin Pharmacol. 2011 Jan;67(1):63-71. doi: 10.1007/s00228-010-0893-3. Epub 2010 Sep 21.","Kummer O","Eur J Clin Pharmacol","2011","2010/09/22","","","10.1007/s00228-010-0893-3"
"20642247","Long-term tolerability and effectiveness of oxymorphone extended release in patients with cancer","Slatkin NE, Rhiner MI, Gould EM, Ma T, Ahdieh H.","J Opioid Manag. 2010 May-Jun;6(3):181-91. doi: 10.5055/jom.2010.0016.","Slatkin NE","J Opioid Manag","2010","2010/07/21","","","10.5055/jom.2010.0016"
"20609129","Negligible analgesic tolerance seen with extended release oxymorphone: a post hoc analysis of open-label longitudinal data","Harden RN, Gagnon CM, Graciosa J, Gould EM.","Pain Med. 2010 Aug;11(8):1198-208. doi: 10.1111/j.1526-4637.2010.00898.x. Epub 2010 Jun 30.","Harden RN","Pain Med","2010","2010/07/09","","","10.1111/j.1526-4637.2010.00898.x"
"20590588","Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safety","Samer CF, Daali Y, Wagner M, Hopfgartner G, Eap CB, Rebsamen MC, Rossier MF, Hochstrasser D, Dayer P, Desmeules JA.","Br J Pharmacol. 2010 Jun;160(4):919-30. doi: 10.1111/j.1476-5381.2010.00709.x.","Samer CF","Br J Pharmacol","2010","2010/07/02","PMC2935998","","10.1111/j.1476-5381.2010.00709.x"
"20521870","Factors affecting acceptability of titrated oxymorphone extended release in chronic low back pain - an individual patient analysis","Peniston JH, Xiang Q, Gould EM.","Curr Med Res Opin. 2010 Aug;26(8):1861-71. doi: 10.1185/03007995.2010.490457.","Peniston JH","Curr Med Res Opin","2010","2010/06/05","","","10.1185/03007995.2010.490457"
"20433374","Fluid balance, glomerular filtration rate, and urine output in dogs anesthetized for an orthopedic surgical procedure","Boscan P, Pypendop BH, Siao KT, Francey T, Dowers K, Cowgill L, Ilkiw JE.","Am J Vet Res. 2010 May;71(5):501-7. doi: 10.2460/ajvr.71.5.501.","Boscan P","Am J Vet Res","2010","2010/05/04","","","10.2460/ajvr.71.5.501"
"20223105","Improved oxymorphone detection in postmortem specimens","Moore C, Vincent M.","J Anal Toxicol. 2010 Mar;34(2):112. doi: 10.1093/jat/34.2.112.","Moore C","J Anal Toxicol","2010","2010/03/13","","","10.1093/jat/34.2.112"
"20223099","Evaluation of the usefulness of an oxycodone immunoassay in combination with a traditional opiate immunoassay for the screening of opiates in urine","Gingras M, Laberge MH, Lefebvre M.","J Anal Toxicol. 2010 Mar;34(2):78-83. doi: 10.1093/jat/34.2.78.","Gingras M","J Anal Toxicol","2010","2010/03/13","","","10.1093/jat/34.2.78"
"20189994","Morphine-like opiates selectively antagonize receptor-arrestin interactions","Molinari P, Vezzi V, Sbraccia M, Grò C, Riitano D, Ambrosio C, Casella I, Costa T.","J Biol Chem. 2010 Apr 23;285(17):12522-35. doi: 10.1074/jbc.M109.059410. Epub 2010 Feb 26.","Molinari P","J Biol Chem","2010","2010/03/02","PMC2857100","","10.1074/jbc.M109.059410"
"20152592","A systematic review of oxymorphone in the management of chronic pain","Mayyas F, Fayers P, Kaasa S, Dale O.","J Pain Symptom Manage. 2010 Feb;39(2):296-308. doi: 10.1016/j.jpainsymman.2009.07.010.","Mayyas F","J Pain Symptom Manage","2010","2010/02/16","","","10.1016/j.jpainsymman.2009.07.010"
"20138595","Quantitation of polar analytes using column-switching: application to oxycodone and three metabolites in human plasma","Wagner M, Bourgogne E, Varesio E, Hopfgartner G.","J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Mar 1;878(7-8):637-44. doi: 10.1016/j.jchromb.2010.01.014. Epub 2010 Jan 18.","Wagner M","J Chromatogr B Analyt Technol Biomed Life Sci","2010","2010/02/09","","","10.1016/j.jchromb.2010.01.014"
"20077093","Quantitation of morphine, codeine, hydrocodone, hydromorphone, oxycodone, oxymorphone, and 6-monoacetylmorphine (6-MAM) in urine, blood, serum, or plasma using liquid chromatography with tandem mass spectrometry detection","Dahn T, Gunn J, Kriger S, Terrell AR.","Methods Mol Biol. 2010;603:411-22. doi: 10.1007/978-1-60761-459-3_40.","Dahn T","Methods Mol Biol","2010","2010/01/16","","","10.1007/978-1-60761-459-3_40"
"20076952","Effects of itraconazole on the pharmacokinetics and pharmacodynamics of intravenously and orally administered oxycodone","Saari TI, Grönlund J, Hagelberg NM, Neuvonen M, Laine K, Neuvonen PJ, Olkkola KT.","Eur J Clin Pharmacol. 2010 Apr;66(4):387-97. doi: 10.1007/s00228-009-0775-8.","Saari TI","Eur J Clin Pharmacol","2010","2010/01/16","","","10.1007/s00228-009-0775-8"
"20050794","Oral oxymorphone #181","Rosielle DA.","J Palliat Med. 2010 Jan;13(1):78-9. doi: 10.1089/jpm.2010.9893.","Rosielle DA","J Palliat Med","2010","2010/01/07","","","10.1089/jpm.2010.9893"
"20040137","Case report: Oxymorphone-involved fatalities: a report of two cases","McIntyre IM, Sherrard JL, Nelson CL.","J Anal Toxicol. 2009 Nov-Dec;33(9):615-9. doi: 10.1093/jat/33.9.615.","McIntyre IM","J Anal Toxicol","2009","2009/12/31","","","10.1093/jat/33.9.615"
"20036472","Urine testing for norcodeine, norhydrocodone, and noroxycodone facilitates interpretation and reduces false negatives","Cone EJ, Zichterman A, Heltsley R, Black DL, Cawthon B, Robert T, Moser F, Caplan YH.","Forensic Sci Int. 2010 May 20;198(1-3):58-61. doi: 10.1016/j.forsciint.2009.12.005. Epub 2009 Dec 29.","Cone EJ","Forensic Sci Int","2010","2009/12/29","","","10.1016/j.forsciint.2009.12.005"
"19800397","Novel approach to demonstrate high efficacy of mu opioids in the rat vas deferens: a simple model of predictive value","Riba P, Friedmann T, Király KP, Al-Khrasani M, Sobor M, Asim MF, Spetea M, Schmidhammer H, Furst S.","Brain Res Bull. 2010 Jan 15;81(1):178-84. doi: 10.1016/j.brainresbull.2009.09.011.","Riba P","Brain Res Bull","2010","2009/10/06","","","10.1016/j.brainresbull.2009.09.011"
"19719813","Impact of the CYP2D6 genotype on post-operative intravenous oxycodone analgesia","Zwisler ST, Enggaard TP, Mikkelsen S, Brosen K, Sindrup SH.","Acta Anaesthesiol Scand. 2010 Feb;54(2):232-40. doi: 10.1111/j.1399-6576.2009.02104.x. Epub 2009 Aug 31.","Zwisler ST","Acta Anaesthesiol Scand","2010","2009/09/02","","","10.1111/j.1399-6576.2009.02104.x"
"19614559","Considerations on the use of oxymorphone in geriatric patients","Pergolizzi JV, Raffa RB, Gould E.","Expert Opin Drug Saf. 2009 Sep;8(5):603-13. doi: 10.1517/14740330903153854.","Pergolizzi JV","Expert Opin Drug Saf","2009","2009/07/21","","","10.1517/14740330903153854"
"19513349","Hypothesis on reciprocal interactions between the central and peripheral components of the endogenous opioid system","Sudakov SK, Trigub MM.","Bull Exp Biol Med. 2008 Dec;146(6):663-6. doi: 10.1007/s10517-009-0368-7.","Sudakov SK","Bull Exp Biol Med","2008","2009/06/11","","","10.1007/s10517-009-0368-7"
"19371460","Concentration of oxymorphone in postmortem fluids and tissue","Garside D, Hargrove RL, Winecker RE.","J Anal Toxicol. 2009 Apr;33(3):121-8. doi: 10.1093/jat/33.3.121.","Garside D","J Anal Toxicol","2009","2009/04/18","","","10.1093/jat/33.3.121"
"19351868","Pharmacokinetics and behavioral effects of an extended-release, liposome-encapsulated preparation of oxymorphone in rhesus macaques","Krugner-Higby L, KuKanich B, Schmidt B, Heath TD, Brown C, Smith LJ.","J Pharmacol Exp Ther. 2009 Jul;330(1):135-41. doi: 10.1124/jpet.108.150052. Epub 2009 Apr 7.","Krugner-Higby L","J Pharmacol Exp Ther","2009","2009/04/09","PMC2700165","","10.1124/jpet.108.150052"
"19333156","The pain quality response profile of oxymorphone extended release in the treatment of low back pain","Gould EM, Jensen MP, Victor TW, Gammaitoni AR, White RE, Galer BS.","Clin J Pain. 2009 Feb;25(2):116-22. doi: 10.1097/AJP.0b013e3181817ac8.","Gould EM","Clin J Pain","2009","2009/04/01","","","10.1097/AJP.0b013e3181817ac8"
"19302907","Oxymorphone extended release for the treatment of chronic low back pain: a retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use","Peniston JH, Gould E.","Clin Ther. 2009 Feb;31(2):347-59. doi: 10.1016/j.clinthera.2009.02.019.","Peniston JH","Clin Ther","2009","2009/03/24","","","10.1016/j.clinthera.2009.02.019"
"19281600","The hypoalgesic effect of oxycodone in human experimental pain models in relation to the CYP2D6 oxidation polymorphism","Zwisler ST, Enggaard TP, Noehr-Jensen L, Pedersen RS, Mikkelsen S, Nielsen F, Brosen K, Sindrup SH.","Basic Clin Pharmacol Toxicol. 2009 Apr;104(4):335-44. doi: 10.1111/j.1742-7843.2009.00378.x. Epub 2009 Feb 27.","Zwisler ST","Basic Clin Pharmacol Toxicol","2009","2009/03/14","","","10.1111/j.1742-7843.2009.00378.x"
"19198809","Comparison of the developmental effects of 5-methoxy-N,N-diisopropyltryptamine (Foxy) to (+/-)-3,4-methylenedioxymethamphetamine (ecstasy) in rats","Skelton MR, Schaefer TL, Herring NR, Grace CE, Vorhees CV, Williams MT.","Psychopharmacology (Berl). 2009 Jun;204(2):287-97. doi: 10.1007/s00213-009-1459-x. Epub 2009 Feb 6.","Skelton MR","Psychopharmacology (Berl)","2009","2009/02/10","PMC2888297","NIHMS207876","10.1007/s00213-009-1459-x"
"19137130","Oxymorphone: a mature molecule with new life","Gimbel JS.","Drugs Today (Barc). 2008 Oct;44(10):767-82. doi: 10.1358/dot.2008.44.10.1279154.","Gimbel JS","Drugs Today (Barc)","2008","2009/01/13","","","10.1358/dot.2008.44.10.1279154"
"19000282","Pharmacokinetics and behavioral effects of oxymorphone after intravenous and subcutaneous administration to healthy dogs","KuKanich B, Schmidt BK, Krugner-Higby LA, Toerber S, Smith LJ.","J Vet Pharmacol Ther. 2008 Dec;31(6):580-3. doi: 10.1111/j.1365-2885.2008.00987.x.","KuKanich B","J Vet Pharmacol Ther","2008","2008/11/13","","","10.1111/j.1365-2885.2008.00987.x"
"18950436","Titration with oxymorphone extended release to achieve effective long-term pain relief and improve tolerability in opioid-naive patients with moderate to severe pain","Rauck R, Ma T, Kerwin R, Ahdieh H.","Pain Med. 2008 Oct;9(7):777-85. doi: 10.1111/j.1526-4637.2007.00390.x.","Rauck R","Pain Med","2008","2008/10/28","","","10.1111/j.1526-4637.2007.00390.x"
"18717508","Oxymorphone and oxymorphone extended release: a pharmacotherapeutic review","Sloan PA, Barkin RL.","J Opioid Manag. 2008 May-Jun;4(3):131-44. doi: 10.5055/jom.2008.0018.","Sloan PA","J Opioid Manag","2008","2008/08/23","","","10.5055/jom.2008.0018"
"18612077","Differential activation and trafficking of micro-opioid receptors in brain slices","Arttamangkul S, Quillinan N, Low MJ, von Zastrow M, Pintar J, Williams JT.","Mol Pharmacol. 2008 Oct;74(4):972-9. doi: 10.1124/mol.108.048512. Epub 2008 Jul 8.","Arttamangkul S","Mol Pharmacol","2008","2008/07/10","PMC3125947","NIHMS303447","10.1124/mol.108.048512"
"18520605","Determination of oxycodone, noroxycodone, oxymorphone, and noroxymorphone in human plasma by liquid chromatography-electrospray-tandem mass spectrometry","Neuvonen M, Neuvonen PJ.","Ther Drug Monit. 2008 Jun;30(3):333-40. doi: 10.1097/FTD.0b013e31816e2d4b.","Neuvonen M","Ther Drug Monit","2008","2008/06/04","","","10.1097/FTD.0b013e31816e2d4b"
"18507781","Regarding CYP450 2D6 poor metabolizers","Ahdieh H.","Pain Pract. 2008 Jul-Aug;8(4):329; author reply 330. doi: 10.1111/j.1533-2500.2008.00218_1.x.","Ahdieh H","Pain Pract","2008","2008/05/30","","","10.1111/j.1533-2500.2008.00218_1.x"
"18443639","Effectiveness of opioids in the treatment of chronic non-cancer pain","Trescot AM, Glaser SE, Hansen H, Benyamin R, Patel S, Manchikanti L.","Pain Physician. 2008 Mar;11(2 Suppl):S181-200.","Trescot AM","Pain Physician","2008","2008/06/17","","",""
"18430301","Evidence that morphine is metabolized to hydromorphone but not to oxymorphone","Cone EJ, Caplan YH, Moser F, Robert T, Black D.","J Anal Toxicol. 2008 May;32(4):319-23. doi: 10.1093/jat/32.4.319.","Cone EJ","J Anal Toxicol","2008","2008/04/24","","","10.1093/jat/32.4.319"
"18363580","Comparison of the analgesic efficacy of hydromorphone and oxymorphone in dogs and cats: a randomized blinded study","Bateman SW, Haldane S, Stephens JA.","Vet Anaesth Analg. 2008 Jul;35(4):341-7. doi: 10.1111/j.1467-2995.2007.00387.x. Epub 2008 Mar 19.","Bateman SW","Vet Anaesth Analg","2008","2008/03/28","","","10.1111/j.1467-2995.2007.00387.x"
"18239781","Methylnaloxone suppresses the development of withdrawal syndrome in morphine-dependent rats","Sudakov SK, Rusakova IV, Trigub MM, Pomytkin IA.","Bull Exp Biol Med. 2007 May;143(5):608-10. doi: 10.1007/s10517-007-0194-8.","Sudakov SK","Bull Exp Biol Med","2007","2008/02/02","","","10.1007/s10517-007-0194-8"
"18210674","Letter to the editor. Use of oral oxymorphone","Kerwin R.","Consult Pharm. 2007 Dec;22(12):972-3; author reply 973-4.","Kerwin R","Consult Pharm","2007","2008/01/24","","",""
"18198283","Agonist-specific regulation of mu-opioid receptor desensitization and recovery from desensitization","Virk MS, Williams JT.","Mol Pharmacol. 2008 Apr;73(4):1301-8. doi: 10.1124/mol.107.042952. Epub 2008 Jan 15.","Virk MS","Mol Pharmacol","2008","2008/01/17","PMC3640555","NIHMS456680","10.1124/mol.107.042952"
"18088051","Effects of the opioid analgesic oxymorphone hydrochloride on reproductive function in male and female rats","Shuey DL, Stump DG, Carliss RD, Gerson RJ.","Birth Defects Res B Dev Reprod Toxicol. 2008 Feb;83(1):12-8. doi: 10.1002/bdrb.20138.","Shuey DL","Birth Defects Res B Dev Reprod Toxicol","2008","2007/12/20","","","10.1002/bdrb.20138"
"17988456","Rapid quantification of urinary oxycodone and oxymorphone using fast gas chromatography-mass spectrometry","McKinley S, Snyder JJ, Welsh E, Kazarian CM, Jamerson MH, Klette KL.","J Anal Toxicol. 2007 Oct;31(8):434-41. doi: 10.1093/jat/31.8.434.","McKinley S","J Anal Toxicol","2007","2007/11/09","","","10.1093/jat/31.8.434"
"17973932","Sex differences in the pharmacokinetics, oxidative metabolism and oral bioavailability of oxycodone in the Sprague-Dawley rat","Chan S, Edwards SR, Wyse BD, Smith MT.","Clin Exp Pharmacol Physiol. 2008 Mar;35(3):295-302. doi: 10.1111/j.1440-1681.2007.04821.x. Epub 2007 Oct 31.","Chan S","Clin Exp Pharmacol Physiol","2008","2007/11/02","","","10.1111/j.1440-1681.2007.04821.x"
"17971405","Comment: Oral oxymorphone for pain management","Ahdieh H, White R.","Ann Pharmacother. 2007 Dec;41(12):2074. doi: 10.1345/aph.1H451a. Epub 2007 Oct 30.","Ahdieh H","Ann Pharmacother","2007","2007/11/01","","","10.1345/aph.1H451a"
"17970197","Activation of kappa-opioid receptor as a method for prevention of ischemic and reperfusion arrhythmias: role of protein kinase C and K(ATP) channels","Lishmanov AY, Maslov LN, Lasukova TV, Crawford D, Wong TM.","Bull Exp Biol Med. 2007 Feb;143(2):187-90. doi: 10.1007/s10517-007-0046-6.","Lishmanov AY","Bull Exp Biol Med","2007","2007/11/01","","","10.1007/s10517-007-0046-6"
"17692717","Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: a randomized, double-blind, active- and placebo-controlled, parallel-group trial","Aqua K, Gimbel JS, Singla N, Ma T, Ahdieh H, Kerwin R.","Clin Ther. 2007 Jun;29(6):1000-12. doi: 10.1016/j.clinthera.2007.06.001.","Aqua K","Clin Ther","2007","2007/08/19","","","10.1016/j.clinthera.2007.06.001"
"17661733","Oral extended-release oxymorphone: a new choice for chronic pain relief","Matsumoto AK.","Expert Opin Pharmacother. 2007 Jul;8(10):1515-27. doi: 10.1517/14656566.8.10.1515.","Matsumoto AK","Expert Opin Pharmacother","2007","2007/07/31","","","10.1517/14656566.8.10.1515"
"17658959","Use of oral oxymorphone in the elderly","Guay DR.","Consult Pharm. 2007 May;22(5):417-30. doi: 10.4140/tcp.n.2007.417.","Guay DR","Consult Pharm","2007","2007/07/31","","","10.4140/tcp.n.2007.417"
"17595308","Oral oxymorphone for pain management","Chamberlin KW, Cottle M, Neville R, Tan J.","Ann Pharmacother. 2007 Jul;41(7):1144-52. doi: 10.1345/aph.1H451. Epub 2007 Jun 26.","Chamberlin KW","Ann Pharmacother","2007","2007/06/28","","","10.1345/aph.1H451"
"17544222","Nociception increases during opioid infusion in opioid receptor triple knock-out mice","Juni A, Klein G, Pintar JE, Kest B.","Neuroscience. 2007 Jun 29;147(2):439-44. doi: 10.1016/j.neuroscience.2007.04.030. Epub 2007 Jun 1.","Juni A","Neuroscience","2007","2007/06/05","","","10.1016/j.neuroscience.2007.04.030"
"17383633","Absence of conditioned place preference or reinstatement with bivalent ligands containing mu-opioid receptor agonist and delta-opioid receptor antagonist pharmacophores","Lenard NR, Daniels DJ, Portoghese PS, Roerig SC.","Eur J Pharmacol. 2007 Jul 2;566(1-3):75-82. doi: 10.1016/j.ejphar.2007.02.040. Epub 2007 Mar 3.","Lenard NR","Eur J Pharmacol","2007","2007/03/27","","","10.1016/j.ejphar.2007.02.040"
"17257473","A 12-week, randomized, placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back pain","Katz N, Rauck R, Ahdieh H, Ma T, Gerritsen van der Hoop R, Kerwin R, Podolsky G.","Curr Med Res Opin. 2007 Jan;23(1):117-28. doi: 10.1185/030079906x162692.","Katz N","Curr Med Res Opin","2007","2007/01/30","","","10.1185/030079906x162692"
"17211696","Effect of naloxone-3-glucuronide and N-methylnaloxone on the motility of the isolated rat colon after morphine","Reber P, Brenneisen R, Flogerzi B, Batista C, Netzer P, Scheurer U.","Dig Dis Sci. 2007 Feb;52(2):502-7. doi: 10.1007/s10620-006-9563-9. Epub 2007 Jan 9.","Reber P","Dig Dis Sci","2007","2007/01/11","","","10.1007/s10620-006-9563-9"
"17204264","Local peripheral antinociceptive effects of 14-O-methyloxymorphone derivatives in inflammatory and neuropathic pain in the rat","Obara I, Makuch W, Spetea M, Schütz J, Schmidhammer H, Przewlocki R, Przewlocka B.","Eur J Pharmacol. 2007 Mar 8;558(1-3):60-7. doi: 10.1016/j.ejphar.2006.11.037. Epub 2006 Nov 25.","Obara I","Eur J Pharmacol","2007","2007/01/06","","","10.1016/j.ejphar.2006.11.037"
"17198138","New pain management options: drugs","D'Arcy Y.","Nursing. 2007 Jan;37(1):18-9. doi: 10.1097/00152193-200701000-00013.","D'Arcy Y","Nursing","2007","2007/01/02","","","10.1097/00152193-200701000-00013"
"17179898","Oral oxymorphone (Opana)","","Med Lett Drugs Ther. 2007 Jan 1;49(1251):3-4.","","Med Lett Drugs Ther","2007","2006/12/21","","",""
"17145204","Efficacy and safety of OPANA ER (oxymorphone extended release) for relief of moderate to severe chronic low back pain in opioid-experienced patients: a 12-week, randomized, double-blind, placebo-controlled study","Hale ME, Ahdieh H, Ma T, Rauck R; Oxymorphone ER Study Group 1.","J Pain. 2007 Feb;8(2):175-84. doi: 10.1016/j.jpain.2006.09.011. Epub 2006 Dec 4.","Hale ME","J Pain","2007","2006/12/06","","","10.1016/j.jpain.2006.09.011"
"17138599","Oxymorphone hydrochloride, a potent opioid analgesic, is not carcinogenic in rats or mice","Shuey DL, Woodland C, Tremblay C, Gregson R, Gerson RJ.","Toxicol Sci. 2007 Mar;96(1):162-73. doi: 10.1093/toxsci/kfl178. Epub 2006 Nov 30.","Shuey DL","Toxicol Sci","2007","2006/12/02","","","10.1093/toxsci/kfl178"
"17098487","Low-level quantitation of oxycodone and its oxidative metabolites, noroxycodone, and oxymorphone, in rat plasma by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry","Edwards SR, Smith MT.","J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Apr 1;848(2):264-70. doi: 10.1016/j.jchromb.2006.10.039. Epub 2006 Nov 13.","Edwards SR","J Chromatogr B Analyt Technol Biomed Life Sci","2007","2006/11/14","","","10.1016/j.jchromb.2006.10.039"
"17077185","Evidence that oxymorphone-induced increases in micronuclei occur secondary to hyperthermia","Shuey DL, Gudi R, Krsmanovic L, Gerson RJ.","Toxicol Sci. 2007 Feb;95(2):369-75. doi: 10.1093/toxsci/kfl148. Epub 2006 Oct 31.","Shuey DL","Toxicol Sci","2007","2006/11/02","","","10.1093/toxsci/kfl148"
"17006080","Antinociception by spinal and systemic oxycodone: why does the route make a difference? In vitro and in vivo studies in rats","Lemberg KK, Kontinen VK, Siiskonen AO, Viljakka KM, Yli-Kauhaluoma JT, Korpi ER, Kalso EA.","Anesthesiology. 2006 Oct;105(4):801-12. doi: 10.1097/00000542-200610000-00027.","Lemberg KK","Anesthesiology","2006","2006/09/29","","","10.1097/00000542-200610000-00027"
"16802855","Comparison of oxycodone pharmacokinetics after buccal and sublingual administration in children","Kokki H, Rasanen I, Lasalmi M, Lehtola S, Ranta VP, Vanamo K, Ojanperä I.","Clin Pharmacokinet. 2006;45(7):745-54. doi: 10.2165/00003088-200645070-00009.","Kokki H","Clin Pharmacokinet","2006","2006/06/29","","","10.2165/00003088-200645070-00009"
"16750450","A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee","Kivitz A, Ma C, Ahdieh H, Galer BS.","Clin Ther. 2006 Mar;28(3):352-64. doi: 10.1016/j.clinthera.2006.03.008.","Kivitz A","Clin Ther","2006","2006/06/06","","","10.1016/j.clinthera.2006.03.008"
"16419399","Evaluation of the DRI oxycodone immunoassay for the detection of oxycodone in urine","Backer RC, Monforte JR, Poklis A.","J Anal Toxicol. 2005 Oct;29(7):675-7. doi: 10.1093/jat/29.7.675.","Backer RC","J Anal Toxicol","2005","2006/01/20","","","10.1093/jat/29.7.675"
"16412134","Effects of oxymorphone and hydromorphone on the minimum alveolar concentration of isoflurane in dogs","Machado CE, Dyson DH, Grant Maxie M.","Vet Anaesth Analg. 2006 Jan;33(1):70-7. doi: 10.1111/j.1467-2995.2005.00215.x.","Machado CE","Vet Anaesth Analg","2006","2006/01/18","","","10.1111/j.1467-2995.2005.00215.x"
"16344024","Efficacy and safety of oxymorphone immediate release for the treatment of mild to moderate pain after ambulatory orthopedic surgery: results of a randomized, double-blind, placebo-controlled trial","Gimbel JS, Walker D, Ma T, Ahdieh H.","Arch Phys Med Rehabil. 2005 Dec;86(12):2284-9. doi: 10.1016/j.apmr.2005.07.303.","Gimbel JS","Arch Phys Med Rehabil","2005","2005/12/14","","","10.1016/j.apmr.2005.07.303"
"16343768","Opioid receptor-mediated hyperalgesia and antinociceptive tolerance induced by sustained opiate delivery","Gardell LR, King T, Ossipov MH, Rice KC, Lai J, Vanderah TW, Porreca F.","Neurosci Lett. 2006 Mar 20;396(1):44-9. doi: 10.1016/j.neulet.2005.11.009. Epub 2005 Dec 15.","Gardell LR","Neurosci Lett","2006","2005/12/14","","","10.1016/j.neulet.2005.11.009"
"16317569","Oxymorphone: a review","Prommer E.","Support Care Cancer. 2006 Feb;14(2):109-15. doi: 10.1007/s00520-005-0917-1. Epub 2005 Nov 30.","Prommer E","Support Care Cancer","2006","2005/12/01","","","10.1007/s00520-005-0917-1"
"16266356","Oxymorphone extended-release tablets relieve moderate to severe pain and improve physical function in osteoarthritis: results of a randomized, double-blind, placebo- and active-controlled phase III trial","Matsumoto AK, Babul N, Ahdieh H.","Pain Med. 2005 Sep-Oct;6(5):357-66. doi: 10.1111/j.1526-4637.2005.00057.x.","Matsumoto AK","Pain Med","2005","2005/11/04","","","10.1111/j.1526-4637.2005.00057.x"
"16111163","Evaluation of induction by use of a combination of oxymorphone and diazepam or hydromorphone and diazepam and maintenance of anesthesia by use of isoflurane in dogs with experimentally induced hypovolemia","Machado CG, Dyson DH, Mathews KA.","Am J Vet Res. 2005 Jul;66(7):1227-37. doi: 10.2460/ajvr.2005.66.1227.","Machado CG","Am J Vet Res","2005","2005/08/23","","","10.2460/ajvr.2005.66.1227"
"16105253","GC-MS quantitation of codeine, morphine, 6-acetylmorphine, hydrocodone, hydromorphone, oxycodone, and oxymorphone in blood","Meatherall R.","J Anal Toxicol. 2005 Jul-Aug;29(5):301-8. doi: 10.1093/jat/29.5.301.","Meatherall R","J Anal Toxicol","2005","2005/08/18","","","10.1093/jat/29.5.301"
"15920941","Measurements of plasma oxycodone, noroxycodone and oxymorphone levels in a patient with bilateral nephrectomy who is undergoing haemodialysis","Lee MA, Leng ME, Cooper RM.","Palliat Med. 2005 Apr;19(3):259-60. doi: 10.1191/0269216305pm1004cr.","Lee MA","Palliat Med","2005","2005/06/01","","","10.1191/0269216305pm1004cr"
"15857143","Synthesis and biological evaluation of 14-alkoxymorphinans. 22.(1) Influence of the 14-alkoxy group and the substitution in position 5 in 14-alkoxymorphinan-6-ones on in vitro and in vivo activities","Lattanzi R, Spetea M, Schüllner F, Rief SB, Krassnig R, Negri L, Schmidhammer H.","J Med Chem. 2005 May 5;48(9):3372-8. doi: 10.1021/jm040894o.","Lattanzi R","J Med Chem","2005","2005/04/29","","","10.1021/jm040894o"
"15777102","Single- and multiple-dose pharmacokinetic and dose-proportionality study of oxymorphone immediate-release tablets","Adams MP, Ahdieh H.","Drugs R D. 2005;6(2):91-9. doi: 10.2165/00126839-200506020-00004.","Adams MP","Drugs R D","2005","2005/03/22","","","10.2165/00126839-200506020-00004"
"15767827","Safety, tolerability, and effectiveness of oxymorphone extended release for moderate to severe osteoarthritis pain: a one-year study","McIlwain H, Ahdieh H.","Am J Ther. 2005 Mar-Apr;12(2):106-12. doi: 10.1097/01.mjt.0000139442.65914.f9.","McIlwain H","Am J Ther","2005","2005/03/16","","","10.1097/01.mjt.0000139442.65914.f9"
"15703368","Oxymorphone extended release does not affect CYP2C9 or CYP3A4 metabolic pathways","Adams M, Pieniaszek HJ Jr, Gammaitoni AR, Ahdieh H.","J Clin Pharmacol. 2005 Mar;45(3):337-45. doi: 10.1177/0091270004271969.","Adams M","J Clin Pharmacol","2005","2005/02/11","","","10.1177/0091270004271969"
"15698850","Gluten exorphin B5 stimulates prolactin secretion through opioid receptors located outside the blood-brain barrier","Fanciulli G, Dettori A, Demontis MP, Tomasi PA, Anania V, Delitala G.","Life Sci. 2005 Feb 25;76(15):1713-9. doi: 10.1016/j.lfs.2004.09.023. Epub 2004 Dec 20.","Fanciulli G","Life Sci","2005","2005/02/09","","","10.1016/j.lfs.2004.09.023"
"15629415","Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study","Hale ME, Dvergsten C, Gimbel J.","J Pain. 2005 Jan;6(1):21-8. doi: 10.1016/j.jpain.2004.09.005.","Hale ME","J Pain","2005","2005/01/05","","","10.1016/j.jpain.2004.09.005"
"15575370","Evaluation of liposome-encapsulated oxymorphone hydrochloride in mice after splenectomy","Clark MD, Krugner-Higby L, Smith LJ, Heath TD, Clark KL, Olson D.","Comp Med. 2004 Oct;54(5):558-63.","Clark MD","Comp Med","2004","2004/12/04","","",""
"15538638","Effectiveness and safety of oral extended-release oxymorphone for the treatment of cancer pain: a pilot study","Sloan P, Slatkin N, Ahdieh H.","Support Care Cancer. 2005 Jan;13(1):57-65. doi: 10.1007/s00520-004-0731-1. Epub 2004 Nov 9.","Sloan P","Support Care Cancer","2005","2004/11/13","","","10.1007/s00520-004-0731-1"
"15502051","The efficacy and safety of oral immediate-release oxymorphone for postsurgical pain","Gimbel J, Ahdieh H.","Anesth Analg. 2004 Nov;99(5):1472-7; table of contents. doi: 10.1213/01.ANE.0000132548.91622.B3.","Gimbel J","Anesth Analg","2004","2004/10/27","","","10.1213/01.ANE.0000132548.91622.B3"
"15500576","Sedative effects and serum drug concentrations of oxymorphone and metabolites after subcutaneous administration of a liposome-encapsulated formulation in dogs","Smith LJ, Krugner-Higby L, Trepanier LA, Flaska DE, Joers V, Heath TD.","J Vet Pharmacol Ther. 2004 Oct;27(5):369-72. doi: 10.1111/j.1365-2885.2004.00582.x.","Smith LJ","J Vet Pharmacol Ther","2004","2004/10/27","","","10.1111/j.1365-2885.2004.00582.x"
"15468158","The use of liquid chromatography/mass spectrometry for quantitative analysis of oxycodone, oxymorphone and noroxycodone in Ringer solution, rat plasma and rat brain tissue","Boström E, Jansson B, Hammarlund-Udenaes M, Simonsson US.","Rapid Commun Mass Spectrom. 2004;18(21):2565-76. doi: 10.1002/rcm.1658.","Boström E","Rapid Commun Mass Spectrom","2004","2004/10/07","","","10.1002/rcm.1658"
"15200750","Establishing the dosage equivalency of oxymorphone extended release and oxycodone controlled release in patients with cancer pain: a randomized controlled study","Gabrail NY, Dvergsten C, Ahdieh H.","Curr Med Res Opin. 2004 Jun;20(6):911-8. doi: 10.1185/030079904125003854.","Gabrail NY","Curr Med Res Opin","2004","2004/06/18","","","10.1185/030079904125003854"
"15199081","Efficacy of oxymorphone extended release in postsurgical pain: a randomized clinical trial in knee arthroplasty","Ahdieh H, Ma T, Babul N, Lee D.","J Clin Pharmacol. 2004 Jul;44(7):767-76. doi: 10.1177/0091270004266487.","Ahdieh H","J Clin Pharmacol","2004","2004/06/17","","","10.1177/0091270004266487"
"15171187","Screening postmortem whole blood for oxycodone by ELISA response ratios","Spiehler VR, DeCicco L, McCutcheon JR, Kupiec T, Kemp P.","J Forensic Sci. 2004 May;49(3):621-6.","Spiehler VR","J Forensic Sci","2004","2004/06/03","","",""
"15098800","Pharmacokinetics and dose-proportionality of oxymorphone extended release and its metabolites: results of a randomized crossover study","Adams MP, Ahdieh H.","Pharmacotherapy. 2004 Apr;24(4):468-76. doi: 10.1592/phco.24.5.468.33347.","Adams MP","Pharmacotherapy","2004","2004/04/22","","","10.1592/phco.24.5.468.33347"
"15053751","Cardiopulmonary effects of medetomidine, oxymorphone, or butorphanol in selegiline-treated dogs","Dodam JR, Cohn LA, Durham HE, Szladovits B.","Vet Anaesth Analg. 2004 Apr;31(2):129-37. doi: 10.1111/j.1467-2987.2004.00164.x.","Dodam JR","Vet Anaesth Analg","2004","2004/04/01","","","10.1111/j.1467-2987.2004.00164.x"
"15039299","Quantitative contribution of CYP2D6 and CYP3A to oxycodone metabolism in human liver and intestinal microsomes","Lalovic B, Phillips B, Risler LL, Howald W, Shen DD.","Drug Metab Dispos. 2004 Apr;32(4):447-54. doi: 10.1124/dmd.32.4.447.","Lalovic B","Drug Metab Dispos","2004","2004/03/25","","","10.1124/dmd.32.4.447"
"14998329","Identification of opioid ligands possessing mixed micro agonist/delta antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone [correction of hydropmorphone]","Ananthan S, Khare NK, Saini SK, Seitz LE, Bartlett JL, Davis P, Dersch CM, Porreca F, Rothman RB, Bilsky EJ.","J Med Chem. 2004 Mar 11;47(6):1400-12. doi: 10.1021/jm030311v.","Ananthan S","J Med Chem","2004","2004/03/05","","","10.1021/jm030311v"
"14754382","Antagonism in opioid peptides: the role of conformation","Salvadori S, Temussi PA.","Curr Top Med Chem. 2004;4(1):145-57. doi: 10.2174/1568026043451564.","Salvadori S","Curr Top Med Chem","2004","2004/02/03","","","10.2174/1568026043451564"
"14729121","In vitro opioid activity profiles of 6-amino acid substituted derivatives of 14-O-methyloxymorphone","Spetea M, Friedmann T, Riba P, Schütz J, Wunder G, Langer T, Schmidhammer H, Fürst S.","Eur J Pharmacol. 2004 Jan 12;483(2-3):301-8. doi: 10.1016/j.ejphar.2003.10.049.","Spetea M","Eur J Pharmacol","2004","2004/01/20","","","10.1016/j.ejphar.2003.10.049"
"14453567","A peri-surgical evaluation of oxymorphone","KANE AA.","West Med Med J West. 1962 Jan;3:8-10.","KANE AA","West Med Med J West","1962","1962/01/01","","",""
"14446819","Numorphan in labor. A preliminary report","SIMECKOVA M, SHAW W, POOL E, NICHOLS EE.","Obstet Gynecol. 1960 Jul;16:119-23.","SIMECKOVA M","Obstet Gynecol","1960","1960/07/01","","",""
"14444630","The use of oxymorphone hydrochloride during anesthesia for operations on the head and neck. A preliminary report","SEIGLEMAN M, WASMUTH CE.","Cleve Clin Q. 1960 Jul;27:157-61. doi: 10.3949/ccjm.27.3.157.","SEIGLEMAN M","Cleve Clin Q","1960","1960/07/01","","","10.3949/ccjm.27.3.157"
"14319086","COMPARATIVE STUDIES WITH NARCOTICS AND NARCOTIC ANTAGONISTS IN MAN","FOLDES FF, TORDA TA.","Acta Anaesthesiol Scand. 1965;9:121-38. doi: 10.1111/j.1399-6576.1965.tb00499.x.","FOLDES FF","Acta Anaesthesiol Scand","1965","1965/01/01","","","10.1111/j.1399-6576.1965.tb00499.x"
"14289953","STUDIES ON THE SPECIFICITY OF NARCOTIC ANTAGONISTS","FOLDES FF, SCHAPIRA M, TORDA TA, DUNCALF D, SHIFFMAN HP.","Anesthesiology. 1965 May-Jun;26:320-8. doi: 10.1097/00000542-196505000-00008.","FOLDES FF","Anesthesiology","1965","1965/05/01","","","10.1097/00000542-196505000-00008"
"14268686","USE OF WRITHING TEST FOR EVALUATING ANALGESIC ACTIVITY OF NARCOTIC ANTAGONISTS","BLUMBERG H, WOLF PS, DAYTON HB.","Proc Soc Exp Biol Med. 1965 Mar;118:763-6. doi: 10.3181/00379727-118-29963.","BLUMBERG H","Proc Soc Exp Biol Med","1965","1965/03/01","","","10.3181/00379727-118-29963"
"14196276","CLINICAL OBSERVATIONS ON THE PREANESTHETIC USE OF OXYMORPHONE AND ITS ANTAGONIST, N-ALLYL-NOROXYMORPHONE, IN DOGS","NYTCH TF.","J Am Vet Med Assoc. 1964 Jul 15;145:127-31.","NYTCH TF","J Am Vet Med Assoc","1964","1964/07/15","","",""
"14191433","[PHARMACOLOGICAL STUDIES ON MORPHINE DERIVATIVES. 3. ON THE CHEMICAL STRUCTURE-ACTIVITY RELATIONSHIPS OF 14-HYDROXYMORPHINE DERIVATIVES]","SEKI I, TAKAGI H, KOBAYASHI S.","Yakugaku Zasshi. 1964 Mar;84:280-6.","SEKI I","Yakugaku Zasshi","1964","1964/03/01","","",""
"14179641","A REPORT ON OXYMORPHONE IN A PODIATRIC PRACTICE","ENGEL DA.","J Am Podiatry Assoc. 1964 Aug;54:554-5.","ENGEL DA","J Am Podiatry Assoc","1964","1964/08/01","","",""
"14165239","THE CLINICAL EVALUATION OF MORPHINE AND ITS SUBSTITUTES AS ANALGESICS","LASAGNA L.","Pharmacol Rev. 1964 Mar;16:47-83.","LASAGNA L","Pharmacol Rev","1964","1964/03/01","","",""
"14160227","CLINICAL TRIAL OF OXYMORPHONE IN LABOUR","EAMES GM, POOL KR.","Br Med J. 1964 Aug 8;2(5405):353-5. doi: 10.1136/bmj.2.5405.353.","EAMES GM","Br Med J","1964","1964/08/08","PMC1816313","","10.1136/bmj.2.5405.353"
"14140632","THE EFFECT OF SIMULTANEOUSLY ADMINISTERED N-ALLYLNOROXYMORPHOE ON THE RESPIRATORY DEPRESSION INDUCED BY OXYMORPHONE","DEVINE MF, TANNENBAUM PJ, AMOROSO CR, RODMAN T.","Am J Med Sci. 1964 Apr;247:412-21. doi: 10.1097/00000441-196404000-00003.","DEVINE MF","Am J Med Sci","1964","1964/04/01","","","10.1097/00000441-196404000-00003"
"14130285","ANALGESICS FOR THE RELIEF OF PAIN. I. NARCOTIC ANALGESICS","WANG RI.","Wis Med J. 1964 Mar;63:164-5.","WANG RI","Wis Med J","1964","1964/03/01","","",""
"14087717","[ANALYSIS OF OPIUM ALKALOIDS AND THE ALLIED COMPOUNDS. XVII. COLORIMETRIC DETERMINATION OF OXYMORPHONE BY 1-NITROSO-2-NAPHTHOL]","KATO K, SATO K, TSUDA T.","Yakugaku Zasshi. 1963 Aug;83:815-7. doi: 10.1248/yakushi1947.83.8_815.","KATO K","Yakugaku Zasshi","1963","1963/08/01","","","10.1248/yakushi1947.83.8_815"
"14085690","OBSTETRICAL EXPERIENCES WITH NUMORPHAN. PRELIMINARY REPORT ON A NEW ANALGESIC","LOPRESTI CE.","West J Surg Obstet Gynecol. 1963 Sep-Oct;71:234-6.","LOPRESTI CE","West J Surg Obstet Gynecol","1963","1963/09/01","","",""
"14081825","THE CONTROL OF SEVERE PAIN WITH ORAL OXYMORPHONE HYDROCHLORIDE","CASS LJ, FREDERIK WS.","Curr Ther Res Clin Exp. 1963 Nov;5:579-86.","CASS LJ","Curr Ther Res Clin Exp","1963","1963/11/01","","",""
"14046447","OXYMORPHONE, AN EFFECTIVE ANALGESIC IN DOGS AND CATS","PALMINTERI A.","J Am Vet Med Assoc. 1963 Jul 15;143:160-3.","PALMINTERI A","J Am Vet Med Assoc","1963","1963/07/15","","",""
"14035049","Oxymorphone during parturition, its effect on the newborn","KOSTYAL JL.","Pa Med J. 1963 May;66:30-2.","KOSTYAL JL","Pa Med J","1963","1963/05/01","","",""
"14005121","A review of oxymorphone hydrochloride (Numorphan) analgesia employed for general surgery, including clinical experience with five hundred and twenty-eight patients","WASMUTH CE, HOMI J.","Cleve Clin Q. 1961 Oct;28:262-9. doi: 10.3949/ccjm.28.4.262.","WASMUTH CE","Cleve Clin Q","1961","1961/10/01","","","10.3949/ccjm.28.4.262"
"13914618","Report on oxymorphone in obstetrics","SNOW DL, SATTENSPIEL E.","Am J Obstet Gynecol. 1962 Jan 1;83:22-4. doi: 10.1016/0002-9378(62)90282-x.","SNOW DL","Am J Obstet Gynecol","1962","1962/01/01","","","10.1016/0002-9378(62)90282-x"
"13911705","A comparison of two narcotics, Numorphan and Demerol, in obstetrics, by doubleblind technique","SHERLINE DM, RODDICK JW Jr.","Q Bull Northwest Univ Med Sch. 1962;36(1):54-6.","SHERLINE DM","Q Bull Northwest Univ Med Sch","1962","1962/01/01","PMC3803928","",""
"13910705","An evaluation of oxymorphone in labor","SENTNOR MH, SOLOMONS E, KOHL SG.","Am J Obstet Gynecol. 1962 Oct 1;84:956-61. doi: 10.1016/0002-9378(62)90074-1.","SENTNOR MH","Am J Obstet Gynecol","1962","1962/10/01","","","10.1016/0002-9378(62)90074-1"
"13893795","The respiratory effects of oxymorphone administered alone or in combination with levallorphan","FOLDES FF, LUNN JN, KLEIN S, SIKER ES.","Am J Med Sci. 1962 Apr;243:480-8. doi: 10.1097/00000441-196204000-00009.","FOLDES FF","Am J Med Sci","1962","1962/04/01","","","10.1097/00000441-196204000-00009"
"13879943","A comparison between oxymorphone (Numorphan) and morphine sulfate prior to pentobarbital anesthesia in the dog","CLIFFORD DH, JHA SK.","Anesth Analg. 1961 Nov-Dec;40:645-9.","CLIFFORD DH","Anesth Analg","1961","1961/11/01","","",""
"13819254","[Physical dependence and tolerance in relation to various analgesics in patients suffering from chronic pains; comparison between morphine, oxymorphone and anileridine]","EDDY NB, LEE LE Jr, HARRIS C.","Bull World Health Organ. 1959;20(6):1245-56.","EDDY NB","Bull World Health Organ","1959","1959/01/01","PMC2537892","",""
"13798620","Relative respiratory depresant effects of oxymorphone (numorphan) and morphine","BELLVILLE JW, ESCARRAGA LA, WALLENSTEIN SL, HOUDE RW, HOWLAND WS.","Anesthesiology. 1960 Jul-Aug;21:397-400. doi: 10.1097/00000542-196007000-00010.","BELLVILLE JW","Anesthesiology","1960","1960/07/01","","","10.1097/00000542-196007000-00010"
"13778580","Comparative toxicities of 14-hydroxydihydromorphinone (oxymorphone) and other narcotic analgesic compounds","TULLAR PE.","Toxicol Appl Pharmacol. 1961 May;3:261-66. doi: 10.1016/0041-008x(61)90065-5.","TULLAR PE","Toxicol Appl Pharmacol","1961","1961/05/01","","","10.1016/0041-008x(61)90065-5"
"13774287","Numorphan: a new supplement to anaesthesia","SWERDLOW M, BROWN PR.","Br J Anaesth. 1961 Mar;33:126-9. doi: 10.1093/bja/33.3.126.","SWERDLOW M","Br J Anaesth","1961","1961/03/01","","","10.1093/bja/33.3.126"
"13757036","[Combined anesthesia with pentothal-numorphan-N2-O]","KNAFF M, RONDEAU Y, von KEERI-SZANTO.","Bull Soc Sci Med Grand Duche Luxemb. 1961 Mar;98:157-60.","KNAFF M","Bull Soc Sci Med Grand Duche Luxemb","1961","1961/03/01","","",""
"13752174","Anesthetic time/dose curves. III. The interaction of thiopental and oxymorphone during surgical anesthesia","KEERI-SZANTO M, KNAFF M, RONDEAU Y.","Clin Pharmacol Ther. 1961 Jul-Aug;2:441-5. doi: 10.1002/cpt196124441.","KEERI-SZANTO M","Clin Pharmacol Ther","1961","1961/07/01","","","10.1002/cpt196124441"
"13752110","Studies of analgesic drugs. V. The comparative subjective effects of oxymorphone and morphine","KEATS AS, TELFORD J.","Clin Pharmacol Ther. 1960 Nov-Dec;1:703-7.","KEATS AS","Clin Pharmacol Ther","1960","1960/11/01","","",""
"13683909","Clinical evaluation and observation of 14-hydroxydihydromorphinone (Numorphan)","APPLETON JC.","Anesth Analg. 1960 Nov-Dec;39:505-10.","APPLETON JC","Anesth Analg","1960","1960/11/01","","",""
"13635165","[A critical evaluation of numorphan: a new synthetic morphine-like alkaloid]","SAMUELS ML, STEHLIN JS, DALE SC, HOWF CD.","South Med J. 1959 Feb;52(2):207-10. doi: 10.1097/00007611-195902000-00015.","SAMUELS ML","South Med J","1959","1959/02/01","","","10.1097/00007611-195902000-00015"
"13631610","The analgesic equivalence to morphine and relative side action liability of oxymorphone (14-hydroxydihydro morphinone)","EDDY NB, LEE LE Jr.","J Pharmacol Exp Ther. 1959 Feb;125(2):116-21.","EDDY NB","J Pharmacol Exp Ther","1959","1959/02/01","","",""
"13369700","The analgesic properties of numorphan (14-hydroxy dihydromorphinone), a new synthetic narcotic","BIERMAN HR, COBLENTZ A.","N Engl J Med. 1956 Oct 11;255(15):694-8. doi: 10.1056/NEJM195610112551504.","BIERMAN HR","N Engl J Med","1956","1956/10/11","","","10.1056/NEJM195610112551504"
"13314877","[Inhibition of levallorphan (N-allyl-3-oxymorphone) considering the emetic and anti-emetic effect of morphine]","PICCINELLI D, CRUCIANI A, DORDONI F.","Arch Ital Sci Farmacol. 1956 Jan;6(1):65-71.","PICCINELLI D","Arch Ital Sci Farmacol","1956","1956/01/01","","",""
"12868573","A single dose of liposome-encapsulated oxymorphone or morphine provides long-term analgesia in an animal model of neuropathic pain","Smith LJ, Krugner-Higby L, Clark M, Wendland A, Heath TD.","Comp Med. 2003 Jun;53(3):280-7.","Smith LJ","Comp Med","2003","2003/07/19","","",""
"12868572","Liposome-encapsulated oxymorphone hydrochloride provides prolonged relief of postsurgical visceral pain in rats","Krugner-Higby L, Smith L, Clark M, Heath TD, Dahly E, Schiffman B, Hubbard-VanStelle S, Ney D, Wendland A.","Comp Med. 2003 Jun;53(3):270-9.","Krugner-Higby L","Comp Med","2003","2003/07/19","","",""
"12757410","Oxymorphone--Endo/Penwest: EN 3202, EN 3203","","Drugs R D. 2003;4(3):204-6. doi: 10.2165/00126839-200304030-00012.","","Drugs R D","2003","2003/05/22","","","10.2165/00126839-200304030-00012"
"12618536","Pharmacokinetic drug interactions of morphine, codeine, and their derivatives: theory and clinical reality, part I","Armstrong SC, Cozza KL.","Psychosomatics. 2003 Mar-Apr;44(2):167-71. doi: 10.1176/appi.psy.44.2.167.","Armstrong SC","Psychosomatics","2003","2003/03/06","","","10.1176/appi.psy.44.2.167"
"12428880","Comparison of the effects of buprenorphine, oxymorphone hydrochloride, and ketoprofen for postoperative analgesia after onychectomy or onychectomy and sterilization in cats","Dobbins S, Brown NO, Shofer FS.","J Am Anim Hosp Assoc. 2002 Nov-Dec;38(6):507-14. doi: 10.5326/0380507.","Dobbins S","J Am Anim Hosp Assoc","2002","2002/11/14","","","10.5326/0380507"
"12216906","Results of preemptive epidural administration of morphine with or without bupivacaine in dogs and cats undergoing surgery: 265 cases (1997-1999)","Troncy E, Junot S, Keroack S, Sammut V, Pibarot P, Genevois JP, Cuvelliez S.","J Am Vet Med Assoc. 2002 Sep 1;221(5):666-72. doi: 10.2460/javma.2002.221.666.","Troncy E","J Am Vet Med Assoc","2002","2002/09/10","","","10.2460/javma.2002.221.666"
"12151069","Investigation of 4,5-epoxymorphinan degradation during analysis by HPLC","Quarry MA, Sebastian DS, Diana F.","J Pharm Biomed Anal. 2002 Aug 22;30(1):99-104. doi: 10.1016/s0731-7085(02)00166-8.","Quarry MA","J Pharm Biomed Anal","2002","2002/08/02","","","10.1016/s0731-7085(02)00166-8"
"12118679","Reliability of goniometry in Labrador Retrievers","Jaegger G, Marcellin-Little DJ, Levine D.","Am J Vet Res. 2002 Jul;63(7):979-86. doi: 10.2460/ajvr.2002.63.979.","Jaegger G","Am J Vet Res","2002","2002/07/18","","","10.2460/ajvr.2002.63.979"
"11958872","Interaction between neuropeptide FF and opioids in the ventral tegmental area in the behavioral response to novelty","Cador M, Marco N, Stinus L, Simonnet G.","Neuroscience. 2002;110(2):309-18. doi: 10.1016/s0306-4522(01)00587-5.","Cador M","Neuroscience","2002","2002/04/18","","","10.1016/s0306-4522(01)00587-5"
"11597422","Derivatives of 17-(2-methylallyl)-substituted noroxymorphone: variation of the delta address and its effects on affinity and selectivity for the delta opioid receptor","Ullrich T, Dersch CM, Rothman RB, Jacobson AE, Rice KC.","Bioorg Med Chem Lett. 2001 Nov 5;11(21):2883-5. doi: 10.1016/s0960-894x(01)00580-7.","Ullrich T","Bioorg Med Chem Lett","2001","2001/10/13","","","10.1016/s0960-894x(01)00580-7"
"11408263","Adaptation of stress-induced mucosal pathophysiology in rat colon involves opioid pathways","Yates DA, Santos J, Söderholm JD, Perdue MH.","Am J Physiol Gastrointest Liver Physiol. 2001 Jul;281(1):G124-8. doi: 10.1152/ajpgi.2001.281.1.G124.","Yates DA","Am J Physiol Gastrointest Liver Physiol","2001","2001/06/16","","","10.1152/ajpgi.2001.281.1.G124"
"11361046","Double-blind, randomized comparison of the analgesic and pharmacokinetic profiles of controlled- and immediate-release oral oxycodone in cancer pain patients","Stambaugh JE, Reder RF, Stambaugh MD, Stambaugh H, Davis M.","J Clin Pharmacol. 2001 May;41(5):500-6. doi: 10.1177/00912700122010375.","Stambaugh JE","J Clin Pharmacol","2001","2001/05/22","","","10.1177/00912700122010375"
"11318359","Effects of hydromorphone or oxymorphone, with or without acepromazine, on preanesthetic sedation, physiologic values, and histamine release in dogs","Smith LJ, Yu JK, Bjorling DE, Waller K.","J Am Vet Med Assoc. 2001 Apr 1;218(7):1101-5. doi: 10.2460/javma.2001.218.1101.","Smith LJ","J Am Vet Med Assoc","2001","2001/04/25","","","10.2460/javma.2001.218.1101"
"11300867","Investigation of the selectivity of oxymorphone- and naltrexone-derived ligands via site-directed mutagenesis of opioid receptors: exploring the ""address"" recognition locus","Metzger TG, Paterlini MG, Ferguson DM, Portoghese PS.","J Med Chem. 2001 Mar 15;44(6):857-62. doi: 10.1021/jm000381r.","Metzger TG","J Med Chem","2001","2001/04/13","","","10.1021/jm000381r"
"11300671","A comparison of two opioid analgesics for relief of visceral pain induced by intestinal resection in rats","Gillingham MB, Clark MD, Dahly EM, Krugner-Higby LA, Ney DM.","Contemp Top Lab Anim Sci. 2001 Jan;40(1):21-6.","Gillingham MB","Contemp Top Lab Anim Sci","2001","2001/04/13","","",""
"11124008","Leg edema from intrathecal opiate infusions","Aldrete JA, Couto da Silva JM.","Eur J Pain. 2000;4(4):361-5. doi: 10.1053/eujp.2000.0199.","Aldrete JA","Eur J Pain","2000","2000/12/22","","","10.1053/eujp.2000.0199"
"11061385","Video-assisted thoracoscopic division of the ligamentum arteriosum in two dogs with persistent right aortic arch","Isakow K, Fowler D, Walsh P.","J Am Vet Med Assoc. 2000 Nov 1;217(9):1333-6. doi: 10.2460/javma.2000.217.1333.","Isakow K","J Am Vet Med Assoc","2000","2000/11/04","","","10.2460/javma.2000.217.1333"
"10854833","Modulation of adenosine concentration by opioid receptor agonists in rat striatum","Halimi G, Devaux C, Clot-Faybesse O, Sampol J, Legof L, Rochat H, Guieu R.","Eur J Pharmacol. 2000 Jun 16;398(2):217-24. doi: 10.1016/s0014-2999(00)00275-2.","Halimi G","Eur J Pharmacol","2000","2000/06/16","","","10.1016/s0014-2999(00)00275-2"
"10766952","A three-dimensional model of the delta-opioid pharmacophore: comparative molecular modeling of peptide and nonpeptide ligands","Shenderovich MD, Liao S, Qian X, Hruby VJ.","Biopolymers. 2000 Jun;53(7):565-80. doi: 10.1002/(SICI)1097-0282(200006)53:7<565::AID-BIP4>3.0.CO;2-5.","Shenderovich MD","Biopolymers","2000","2000/04/15","","","10.1002/(SICI)1097-0282(200006)53:7<565::AID-BIP4>3.0.CO;2-5"
"10754685","Investigation of phenolic bioisosterism in opiates: 3-sulfonamido analogues of naltrexone and oxymorphone","McCurdy CR, Jones RM, Portoghese PS.","Org Lett. 2000 Mar 23;2(6):819-21. doi: 10.1021/ol005561+.","McCurdy CR","Org Lett","2000","2001/02/07","","","10.1021/ol005561+"
"10723604","Hydromorphone: a cost-effective alternative to the use of oxymorphone","Pettifer G, Dyson D.","Can Vet J. 2000 Feb;41(2):135-7.","Pettifer G","Can Vet J","2000","2000/03/21","PMC1476286","",""
"10701990","Distinction among eight opiate drugs in urine by gas chromatography-mass spectrometry","Nowatzke W, Zeng J, Saunders A, Bohrer A, Koenig J, Turk J.","J Pharm Biomed Anal. 1999 Sep;20(5):815-28. doi: 10.1016/s0731-7085(99)00086-2.","Nowatzke W","J Pharm Biomed Anal","1999","2000/03/04","","","10.1016/s0731-7085(99)00086-2"
"10588427","Treatment augmentation with opiates in severe and refractory major depression","Stoll AL, Rueter S.","Am J Psychiatry. 1999 Dec;156(12):2017. doi: 10.1176/ajp.156.12.2017.","Stoll AL","Am J Psychiatry","1999","1999/12/10","","","10.1176/ajp.156.12.2017"
"10415668","D3 dopamine and kappa opioid receptor alterations in human brain of cocaine-overdose victims","Mash DC, Staley JK.","Ann N Y Acad Sci. 1999 Jun 29;877:507-22. doi: 10.1111/j.1749-6632.1999.tb09286.x.","Mash DC","Ann N Y Acad Sci","1999","1999/07/23","","","10.1111/j.1749-6632.1999.tb09286.x"
"10369327","GC-MS confirmation of codeine, morphine, 6-acetylmorphine, hydrocodone, hydromorphone, oxycodone, and oxymorphone in urine","Meatherall R.","J Anal Toxicol. 1999 May-Jun;23(3):177-86. doi: 10.1093/jat/23.3.177.","Meatherall R","J Anal Toxicol","1999","1999/06/16","","","10.1093/jat/23.3.177"
"10218479","Neurologically active plant compounds and peptide hormones: a chirality connection","Fraternali F, Anselmi C, Temussi PA.","FEBS Lett. 1999 Apr 9;448(2-3):217-20. doi: 10.1016/s0014-5793(99)00244-6.","Fraternali F","FEBS Lett","1999","1999/04/28","","","10.1016/s0014-5793(99)00244-6"
"10048551","Cardiovascular effects of epidurally administered oxymorphone and an oxymorphone-bupivacaine combination in halothane-anesthetized dogs","Torske KE, Dyson DH, Conlon PD.","Am J Vet Res. 1999 Feb;60(2):194-200.","Torske KE","Am J Vet Res","1999","1999/02/27","","",""
"9915151","Comparison of transdermal fentanyl and intramuscular oxymorphone on post-operative behaviour after ovariohysterectomy in dogs","Kyles AE, Hardie EM, Hansen BD, Papich MG.","Res Vet Sci. 1998 Nov-Dec;65(3):245-51. doi: 10.1016/s0034-5288(98)90151-5.","Kyles AE","Res Vet Sci","1998","1999/01/23","","","10.1016/s0034-5288(98)90151-5"
"9749518","Antinociceptive effects of oxymorphone-butorphanol-acepromazine combination in cats","Briggs SL, Sneed K, Sawyer DC.","Vet Surg. 1998 Sep-Oct;27(5):466-72. doi: 10.1111/j.1532-950x.1998.tb00158.x.","Briggs SL","Vet Surg","1998","1998/09/28","","","10.1111/j.1532-950x.1998.tb00158.x"
"9712193","Affinity profiles of novel delta-receptor selective benzofuran derivatives of non-peptide opioids","Spetea M, Nevin ST, Hosztafi S, Rónai AZ, Tóth G, Borsodi A.","Neurochem Res. 1998 Sep;23(9):1211-6. doi: 10.1023/a:1020738304036.","Spetea M","Neurochem Res","1998","1998/08/26","","","10.1023/a:1020738304036"
"9685249","Synthesis of 7-arylmorphinans. Probing the ""address"" requirements for selectivity at opioid delta receptors","Gao P, Larson DL, Portoghese PS.","J Med Chem. 1998 Jul 30;41(16):3091-8. doi: 10.1021/jm9802214.","Gao P","J Med Chem","1998","1998/07/31","","","10.1021/jm9802214"
"9651172","14-Desoxy analogues of naltrindole and 7-spiroindanyloxymorphone: the role of the 14-hydroxy group at delta opioid receptors","Kshirsagar TA, Fang X, Portoghese PS.","J Med Chem. 1998 Jul 2;41(14):2657-60. doi: 10.1021/jm980209b.","Kshirsagar TA","J Med Chem","1998","1998/07/03","","","10.1021/jm980209b"
"9635170","End tidal halothane concentration and postoperative analgesia requirements in dogs: a comparison between intravenous oxymorphone and epidural bupivacaine alone and in combination with oxymorphone","Torske KE, Dyson DH, Pettifer G.","Can Vet J. 1998 Jun;39(6):361-9.","Torske KE","Can Vet J","1998","1998/06/23","PMC1539403","",""
"9410864","Assessing pain in animals","Hardie EM.","J Am Vet Med Assoc. 1997 Oct 15;211(8):977-8.","Hardie EM","J Am Vet Med Assoc","1997","1997/12/31","","",""
"9301669","7-spirobenzocyclohexyl derivatives of naltrexone, oxymorphone, and hydromorphone as selective opioid receptor ligands","Fang X, Larson DL, Portoghese PS.","J Med Chem. 1997 Sep 12;40(19):3064-70. doi: 10.1021/jm970283e.","Fang X","J Med Chem","1997","1997/09/25","","","10.1021/jm970283e"
"9269879","Intranasal absorption of oxymorphone","Hussain MA, Aungst BJ.","J Pharm Sci. 1997 Aug;86(8):975-6. doi: 10.1021/js960513x.","Hussain MA","J Pharm Sci","1997","1997/08/01","","","10.1021/js960513x"
"9267504","Comparison of ketoprofen, oxymorphone hydrochloride, and butorphanol in the treatment of postoperative pain in dogs","Pibarot P, Dupuis J, Grisneaux E, Cuvelliez S, Planté J, Beauregard G, Bonneau NH, Bouffard J, Blais D.","J Am Vet Med Assoc. 1997 Aug 15;211(4):438-44.","Pibarot P","J Am Vet Med Assoc","1997","1997/08/15","","",""
"9171881","7-Spiroindanyl derivatives of naltrexone and oxymorphone as selective ligands for delta opioid receptors","Ohkawa S, DiGiacomo B, Larson DL, Takemori AE, Portoghese PS.","J Med Chem. 1997 May 23;40(11):1720-5. doi: 10.1021/jm9700880.","Ohkawa S","J Med Chem","1997","1997/05/23","","","10.1021/jm9700880"
"9061102","Pharmacokinetics and pharmacodynamics of controlled-release opioids","Kaiko RF.","Acta Anaesthesiol Scand. 1997 Jan;41(1 Pt 2):166-74. doi: 10.1111/j.1399-6576.1997.tb04633.x.","Kaiko RF","Acta Anaesthesiol Scand","1997","1997/01/01","","","10.1111/j.1399-6576.1997.tb04633.x"
"8877704","Comparison of cyclic delta-opioid peptides with non-peptide delta-agonist spiroindanyloxymorphone (SIOM) using the message-address concept: a molecular modeling study","Gao P.","J Comput Aided Mol Des. 1996 Aug;10(4):327-36. doi: 10.1007/BF00124502.","Gao P","J Comput Aided Mol Des","1996","1996/08/01","","","10.1007/BF00124502"
"8877043","A comparison of ketorolac with flunixin, butorphanol, and oxymorphone in controlling postoperative pain in dogs","Mathews KA, Paley DM, Foster RA, Valliant AE, Young SS.","Can Vet J. 1996 Sep;37(9):557-67.","Mathews KA","Can Vet J","1996","1996/09/01","PMC1576372","",""
"8810028","Postoperative analgesic and cardiopulmonary effects in dogs of oxymorphone administered epidurally and intramuscularly, and medetomidine administered epidurally: a comparative clinical study","Vesal N, Cribb PH, Frketic M.","Vet Surg. 1996 Jul-Aug;25(4):361-9. doi: 10.1111/j.1532-950x.1996.tb01428.x.","Vesal N","Vet Surg","1996","1996/07/01","","","10.1111/j.1532-950x.1996.tb01428.x"
"8756878","Ability of flumazenil, butorphanol, and naloxone to reverse the anesthetic effects of oxymorphone-diazepam in dogs","Lemke KA, Tranquilli WJ, Thurmon JC, Benson GJ, Olson WA.","J Am Vet Med Assoc. 1996 Aug 15;209(4):776-9.","Lemke KA","J Am Vet Med Assoc","1996","1996/08/15","","",""
"8755978","Epidural administration of bupivacaine, morphine, or their combination for postoperative analgesia in dogs","Hendrix PK, Raffe MR, Robinson EP, Felice LJ, Randall DA.","J Am Vet Med Assoc. 1996 Aug 1;209(3):598-607.","Hendrix PK","J Am Vet Med Assoc","1996","1996/08/01","","",""
"8695073","The pharmacokinetics of oxycodone in uremic patients undergoing renal transplantation","Kirvela M, Lindgren L, Seppala T, Olkkola KT.","J Clin Anesth. 1996 Feb;8(1):13-8. doi: 10.1016/0952-8180(95)00092-5.","Kirvela M","J Clin Anesth","1996","1996/02/01","","","10.1016/0952-8180(95)00092-5"
"8549034","Pharmacokinetic-pharmacodynamic relationships of controlled-release oxycodone","Kaiko RF, Benziger DP, Fitzmartin RD, Burke BE, Reder RF, Goldenheim PD.","Clin Pharmacol Ther. 1996 Jan;59(1):52-61. doi: 10.1016/S0009-9236(96)90024-7.","Kaiko RF","Clin Pharmacol Ther","1996","1996/01/01","","","10.1016/S0009-9236(96)90024-7"
"8545474","Oxymorphone-induced analgesia and colonic motility measured in colorectal distension","Briggs SL, Sawyer DC, Rech RH, Galligan JJ.","Pharmacol Biochem Behav. 1995 Nov;52(3):561-3. doi: 10.1016/0091-3057(95)00140-r.","Briggs SL","Pharmacol Biochem Behav","1995","1995/11/01","","","10.1016/0091-3057(95)00140-r"
"8490994","Peripheral opioidergic mechanisms do not mediate naloxone's pressor effect in the conscious rabbit","Jang W, Schadt JC, Gaddis RR.","Circ Shock. 1993 Feb;39(2):121-7.","Jang W","Circ Shock","1993","1993/02/01","","",""
"8420907","Anesthetic techniques for neutering 6- to 14-week-old kittens","Faggella AM, Aronsohn MG.","J Am Vet Med Assoc. 1993 Jan 1;202(1):56-62.","Faggella AM","J Am Vet Med Assoc","1993","1993/01/01","","",""
"8394935","A selective delta 1 opioid receptor agonist derived from oxymorphone. Evidence for separate recognition sites for delta 1 opioid receptor agonists and antagonists","Portoghese PS, Moe ST, Takemori AE.","J Med Chem. 1993 Aug 20;36(17):2572-4. doi: 10.1021/jm00069a017.","Portoghese PS","J Med Chem","1993","1993/08/20","","","10.1021/jm00069a017"
"8391457","Highly potent novel opioid receptor agonist in the 14-alkoxymetopon series","Fürst Z, Búzás B, Friedmann T, Schmidhammer H, Borsodi A.","Eur J Pharmacol. 1993 May 19;236(2):209-15. doi: 10.1016/0014-2999(93)90591-5.","Fürst Z","Eur J Pharmacol","1993","1993/05/19","","","10.1016/0014-2999(93)90591-5"
"8250399","Influence of anesthetic regimens on the perioperative catecholamine response associated with onychectomy in cats","Lin HC, Benson GJ, Thurmon JC, Tranquilli WJ, Olson WA, Bevill RF.","Am J Vet Res. 1993 Oct;54(10):1721-4.","Lin HC","Am J Vet Res","1993","1993/10/01","","",""
"8140742","Butorphanol tartrate for partial reversal of oxymorphone-induced postoperative respiratory depression in the dog","McCrackin MA, Harvey RC, Sackman JE, McLean RA, Paddleford RR.","Vet Surg. 1994 Jan-Feb;23(1):67-74. doi: 10.1111/j.1532-950x.1994.tb00447.x.","McCrackin MA","Vet Surg","1994","1994/01/01","","","10.1111/j.1532-950x.1994.tb00447.x"
"8138757","A modulatory role of endogenous opioids on prolactin secretion at the end of pregnancy in the rat","Soaje M, Deis RP.","J Endocrinol. 1994 Jan;140(1):97-102. doi: 10.1677/joe.0.1400097.","Soaje M","J Endocrinol","1994","1994/01/01","","","10.1677/joe.0.1400097"
"8091634","Cardiorespiratory effects of four opioid-tranquilizer combinations in dogs","Jacobson JD, McGrath CJ, Smith EP.","Vet Surg. 1994 Jul-Aug;23(4):299-306. doi: 10.1111/j.1532-950x.1994.tb00488.x.","Jacobson JD","Vet Surg","1994","1994/07/01","","","10.1111/j.1532-950x.1994.tb00488.x"
"8068877","Role of endogenous peripheral opioid mechanisms in renal function","DiBona GF, Jones SY.","J Am Soc Nephrol. 1994 Apr;4(10):1792-7.","DiBona GF","J Am Soc Nephrol","1994","1994/04/01","","",""
"8064383","Peripheral regulation of food intake in poultry","Denbow DM.","J Nutr. 1994 Aug;124(8 Suppl):1349S-1354S. doi: 10.1093/jn/124.suppl_8.1349S.","Denbow DM","J Nutr","1994","1994/08/01","","","10.1093/jn/124.suppl_8.1349S"
"8017701","Cardiorespiratory effects of induction and maintenance of anesthesia with ketamine-midazolam combination, with and without prior administration of butorphanol or oxymorphone","Jacobson JD, McGrath CJ, Smith EP.","Am J Vet Res. 1994 Apr;55(4):543-50.","Jacobson JD","Am J Vet Res","1994","1994/04/01","","",""
"7996467","The influence of pharmacogenetics on opioid analgesia: studies with codeine and oxycodone in the Sprague-Dawley/Dark Agouti rat model","Cleary J, Mikus G, Somogyi A, Bochner F.","J Pharmacol Exp Ther. 1994 Dec;271(3):1528-34.","Cleary J","J Pharmacol Exp Ther","1994","1994/12/01","","",""
"7978599","Does naloxone cause a positive urine opiate screen?","Storrow AB, Wians FH Jr, Mikkelsen SL, Norton J.","Ann Emerg Med. 1994 Dec;24(6):1151-3. doi: 10.1016/s0196-0644(94)70247-0.","Storrow AB","Ann Emerg Med","1994","1994/12/01","","","10.1016/s0196-0644(94)70247-0"
"7957512","Respiratory effects and tolerability of Mr 2264 Cl. A new opiate partial agonist in comparison with morphine and placebo","Behne M, Bremerich D, Heinrich J, Schumacher H, Scherer M.","Eur J Clin Pharmacol. 1994;46(4):301-4. doi: 10.1007/BF00194395.","Behne M","Eur J Clin Pharmacol","1994","1994/01/01","","","10.1007/BF00194395"
"7934643","The effects of selective opioid antagonists on somatosensory evoked potentials during relative cerebral ischemia in rats","Gunnarsson T, Sigurdardottir S, Hoffmann P, Skarphedinsson JO.","Life Sci. 1994;55(17):1365-74. doi: 10.1016/0024-3205(94)00769-1.","Gunnarsson T","Life Sci","1994","1994/01/01","","","10.1016/0024-3205(94)00769-1"
"7873130","Opioids and sexual behavior in the male rabbit: the role of central and peripheral opioid receptors","Agmo A, Paredes RG, Contreras JL.","J Neural Transm Gen Sect. 1994;97(3):211-23. doi: 10.1007/BF02336142.","Agmo A","J Neural Transm Gen Sect","1994","1994/01/01","","","10.1007/BF02336142"
"7807224","Administration of opiate antagonist naloxone induces recurrence of increased jaw muscle activities related to inflammatory irritant application to rat temporomandibular joint region","Yu XM, Sessle BJ, Vernon H, Hu JW.","J Neurophysiol. 1994 Sep;72(3):1430-3. doi: 10.1152/jn.1994.72.3.1430.","Yu XM","J Neurophysiol","1994","1994/09/01","","","10.1152/jn.1994.72.3.1430"
"7549039","Naloxone exacerbates intestinal and systemic anaphylaxis in the rat","Djurić VJ, Wang L, Bienenstock J, Perdue MH.","Brain Behav Immun. 1995 Jun;9(2):87-100. doi: 10.1006/brbi.1995.1010.","Djurić VJ","Brain Behav Immun","1995","1995/06/01","","","10.1006/brbi.1995.1010"
"7536861","Forensic drug testing for opiates. VI. Urine testing for hydromorphone, hydrocodone, oxymorphone, and oxycodone with commercial opiate immunoassays and gas chromatography-mass spectrometry","Smith ML, Hughes RO, Levine B, Dickerson S, Darwin WD, Cone EJ.","J Anal Toxicol. 1995 Jan-Feb;19(1):18-26. doi: 10.1093/jat/19.1.18.","Smith ML","J Anal Toxicol","1995","1995/01/01","","","10.1093/jat/19.1.18"
"7500616","Facilitation of thin-layer chromatographic identification of opiates by derivatization with acetic anhydride or methoxyamine","Dietzen DJ, Koenig J, Turk J.","J Anal Toxicol. 1995 Sep;19(5):299-303. doi: 10.1093/jat/19.5.299.","Dietzen DJ","J Anal Toxicol","1995","1995/09/01","","","10.1093/jat/19.5.299"
"7353536","Structure-activity relationships of a synthetic pentapeptide that specifically releases growth hormone in vitro","Bowers CY, Momany F, Reynolds GA, Chang D, Hong A, Chang K.","Endocrinology. 1980 Mar;106(3):663-7. doi: 10.1210/endo-106-3-663.","Bowers CY","Endocrinology","1980","1980/03/01","","","10.1210/endo-106-3-663"
"7104858","A comparison of some pharmacological effects of naloxone and N-methylnaloxone in mice","Ramabadran K, Suaudeau C, Jacob JJ.","Can J Physiol Pharmacol. 1982 May;60(5):715-9. doi: 10.1139/y82-097.","Ramabadran K","Can J Physiol Pharmacol","1982","1982/05/01","","","10.1139/y82-097"
"6330344","New insights in the clastic binding hypothesis for opiate-receptor interactions I: Electron-transfer mechanism","Kolb VM.","J Pharm Sci. 1984 Jun;73(6):715-9. doi: 10.1002/jps.2600730603.","Kolb VM","J Pharm Sci","1984","1984/06/01","","","10.1002/jps.2600730603"
"6321203","Effect of beta-FNA on opiate receptor binding: preliminary evidence for two types of mu receptors","Rothman RB, Bowen WD, Schumacher UK, Pert CB.","Eur J Pharmacol. 1983 Nov 11;95(1-2):147-8. doi: 10.1016/0014-2999(83)90282-0.","Rothman RB","Eur J Pharmacol","1983","1983/11/11","","","10.1016/0014-2999(83)90282-0"
"6320961","Effect of digitonin on the binding of opiate agonists and antagonists to membrane-bound and soluble opioid binding sites","Itzhak Y, Hiller JM, Gioannini TL, Simon EJ.","Brain Res. 1984 Jan 23;291(2):309-15. doi: 10.1016/0006-8993(84)91263-0.","Itzhak Y","Brain Res","1984","1984/01/23","","","10.1016/0006-8993(84)91263-0"
"6314191","Multiple mu receptors: evidence for mu2 sites in the guinea pig ileum","Gintzler AR, Pasternak GW.","Neurosci Lett. 1983 Aug 19;39(1):51-6. doi: 10.1016/0304-3940(83)90164-7.","Gintzler AR","Neurosci Lett","1983","1983/08/19","","","10.1016/0304-3940(83)90164-7"
"6292615","Opioid agonist and antagonist bivalent ligands as receptor probes","Portoghese PS, Ronsisvalle G, Larson DL, Yim CB, Sayre LM, Takemori AE.","Life Sci. 1982 Sep 20-27;31(12-13):1283-6. doi: 10.1016/0024-3205(82)90362-9.","Portoghese PS","Life Sci","1982","1982/09/20","","","10.1016/0024-3205(82)90362-9"
"6287349","Opiate, enkephalin, and endorphin analgesia: relations to a single subpopulation of opiate receptors","Pasternak GW.","Neurology. 1981 Oct;31(10):1311-5. doi: 10.1212/wnl.31.10.1311.","Pasternak GW","Neurology","1981","1981/10/01","","","10.1212/wnl.31.10.1311"
"6263637","The irreversible narcotic antagonistic and reversible agonistic properties of the fumaramate methyl ester derivative of naltrexone","Takemori AE, Larson DL, Portoghese PS.","Eur J Pharmacol. 1981 Apr 9;70(4):445-51. doi: 10.1016/0014-2999(81)90355-1.","Takemori AE","Eur J Pharmacol","1981","1981/04/09","","","10.1016/0014-2999(81)90355-1"
"6258111","Endogenous opioids and social behavior","Panksepp J, Herman BH, Vilberg T, Bishop P, DeEskinazi FG.","Neurosci Biobehav Rev. 1980 Winter;4(4):473-87. doi: 10.1016/0149-7634(80)90036-6.","Panksepp J","Neurosci Biobehav Rev","1980","1980/01/01","","","10.1016/0149-7634(80)90036-6"
"6245210","A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities","Portoghese PS, Larson DL, Sayre LM, Fries DS, Takemori AE.","J Med Chem. 1980 Mar;23(3):233-4. doi: 10.1021/jm00177a002.","Portoghese PS","J Med Chem","1980","1980/03/01","","","10.1021/jm00177a002"
"6209395","Diastereomeric 6-desoxy-6-spiro-alpha-methylene-gamma-butyrolactone derivatives of naltrexone and oxymorphone. Selective irreversible inhibition of naltrexone binding in an opioid receptor preparation by a conformationally restricted michael acceptor ligand","Koolpe GA, Nelson WL, Gioannini TL, Angel L, Simon EJ.","J Med Chem. 1984 Dec;27(12):1718-23. doi: 10.1021/jm00378a032.","Koolpe GA","J Med Chem","1984","1984/12/01","","","10.1021/jm00378a032"
"6208826","Cystometry in dogs under oxymorphone and acepromazine restraint","Barsanti JA, Mahaffey MB, Crowell WA, Barber DL.","Am J Vet Res. 1984 Oct;45(10):2152-3.","Barsanti JA","Am J Vet Res","1984","1984/10/01","","",""
"6207431","Irreversible and reversible narcotic agonists: discriminative and analgesic effects of buprenorphine, oxymorphazone, and morphine","France CP, Jacobson AE, Woods JH.","NIDA Res Monogr. 1984 Mar;49:136-42.","France CP","NIDA Res Monogr","1984","1984/03/01","","",""
"6206435","Tritiated-6-beta-fluoro-6-desoxy-oxymorphone: a highly selective ligand for the opiate mu receptor whose binding is characterized by low nonspecific binding","Rothman RB, Danks JA, Jacobson AE, Burke TR Jr, Rice KC, Pert CB.","Neuropeptides. 1984 Jun;4(4):311-7. doi: 10.1016/0143-4179(84)90005-2.","Rothman RB","Neuropeptides","1984","1984/06/01","","","10.1016/0143-4179(84)90005-2"
"6206224","Discriminative stimulus effects of reversible and irreversible opiate agonists: morphine, oxymorphazone and buprenorphine","France CP, Jacobson AE, Woods JH.","J Pharmacol Exp Ther. 1984 Sep;230(3):652-7.","France CP","J Pharmacol Exp Ther","1984","1984/09/01","","",""
"6204757","Oxymorphazone: a long-acting opiate analgesic","Ling GS, Galetta S, Pasternak GW.","Cell Mol Neurobiol. 1984 Mar;4(1):1-13. doi: 10.1007/BF00710938.","Ling GS","Cell Mol Neurobiol","1984","1984/03/01","","","10.1007/BF00710938"
"6202532","Local inhibition of inflammatory pain by naloxone and its N-methyl quaternary analogue","Rios L, Jacob JJ.","Eur J Pharmacol. 1983 Dec 23;96(3-4):277-83. doi: 10.1016/0014-2999(83)90317-5.","Rios L","Eur J Pharmacol","1983","1983/12/23","","","10.1016/0014-2999(83)90317-5"
"6199340","Xylazine-ketamine-oxymorphone: an injectable anesthetic combination in swine","Breese CE, Dodman NH.","J Am Vet Med Assoc. 1984 Jan 15;184(2):182-3.","Breese CE","J Am Vet Med Assoc","1984","1984/01/15","","",""
"6198981","An etorphine-evoked vagal reflex in rats is inhibited by naloxone, N-methylnaloxone, and SMS 201-995","Dashwood MR, Kiang JG, Wei ET.","Arch Int Pharmacodyn Ther. 1983 Nov;266(1):77-82.","Dashwood MR","Arch Int Pharmacodyn Ther","1983","1983/11/01","","",""
"6198696","Fluid consumption in water-deprived rats after administration of naloxone or quaternary naloxone","Turkish S, Cooper SJ.","Prog Neuropsychopharmacol Biol Psychiatry. 1983;7(4-6):835-9. doi: 10.1016/0278-5846(83)90078-7.","Turkish S","Prog Neuropsychopharmacol Biol Psychiatry","1983","1983/01/01","","","10.1016/0278-5846(83)90078-7"
"6197862","[Synthesis of long-acting analgesic hydrazone derivatives of 14-hydroxycodeinone and 14-hydroxymorphine]","Liu MQ, Chi CJ, Guo YM, Zhu CL.","Yao Xue Xue Bao. 1983 Jun;18(6):475-7.","Liu MQ","Yao Xue Xue Bao","1983","1983/06/01","","",""
"6197313","Quaternary opiate antagonists lower blood pressure and inhibit leucine-enkephalin responses","Giles T, Sander G, Merz H.","Eur J Pharmacol. 1983 Nov 25;95(3-4):247-52. doi: 10.1016/0014-2999(83)90641-6.","Giles T","Eur J Pharmacol","1983","1983/11/25","","","10.1016/0014-2999(83)90641-6"
"6194952","Oxymorphone metabolism and urinary excretion in human, rat, guinea pig, rabbit, and dog","Cone EJ, Darwin WD, Buchwald WF, Gorodetzky CW.","Drug Metab Dispos. 1983 Sep-Oct;11(5):446-50.","Cone EJ","Drug Metab Dispos","1983","1983/09/01","","",""
"6193028","Morphine tissue levels and reduction of gastrointestinal transit in rats. Correlation supports primary action site in the gut","Bianchi G, Ferretti P, Recchia M, Rocchetti M, Tavani A, Manara L.","Gastroenterology. 1983 Oct;85(4):852-8.","Bianchi G","Gastroenterology","1983","1983/10/01","","",""
"6188019","Opiates and their antagonists modulate luteinizing hormone acting outside the blood brain barrier","Panerai AE, Martini A, Casanueva F, Petraglia F, Di Giulio AM, Mantegazza P.","Life Sci. 1983 Apr 11;32(15):1751-6. doi: 10.1016/0024-3205(83)90838-x.","Panerai AE","Life Sci","1983","1983/04/11","","","10.1016/0024-3205(83)90838-x"
"6187025","Effects of naloxone and its quaternary form on fluid consumption in rats","Hemmer RC, Olson GA, Kastin AJ, McLean JH, Olson RD.","Pharmacol Biochem Behav. 1982 Dec;17(6):1287-90. doi: 10.1016/0091-3057(82)90136-8.","Hemmer RC","Pharmacol Biochem Behav","1982","1982/12/01","","","10.1016/0091-3057(82)90136-8"
"6186879","Pharmacological actions of levallorphan allyl bromide (CM 32191), a new peripheral narcotic antagonist","Bianchetti A, Giudice A, Picerno N, Carminati P.","Life Sci. 1982 Nov 15-22;31(20-21):2261-4. doi: 10.1016/0024-3205(82)90133-3.","Bianchetti A","Life Sci","1982","1982/11/15","","","10.1016/0024-3205(82)90133-3"
"6183551","Receptor binding and analgesic properties of oxymorphazone","Galetta S, Ling GS, Wolfin L, Pasternak GW.","Life Sci. 1982 Sep 20-27;31(12-13):1389-92. doi: 10.1016/0024-3205(82)90388-5.","Galetta S","Life Sci","1982","1982/09/20","","","10.1016/0024-3205(82)90388-5"
"6183550","Inhibition of gastrointestinal transit by morphine and FK 33-824 in the rat and comparative narcotic antagonist properties of naloxone and its N-methyl quaternary analog","Manara L, Bianchi G, Fiocchi R, Notarnicola A, Peracchia F, Tavani A.","Life Sci. 1982 Sep 20-27;31(12-13):1271-4. doi: 10.1016/0024-3205(82)90359-9.","Manara L","Life Sci","1982","1982/09/20","","","10.1016/0024-3205(82)90359-9"
"6183549","Effects of N-methylnaloxone and N-methylnaltrexone on nociception and precipitated abstinence in mice","Ramabadran K.","Life Sci. 1982 Sep 20-27;31(12-13):1253-6. doi: 10.1016/0024-3205(82)90355-1.","Ramabadran K","Life Sci","1982","1982/09/20","","","10.1016/0024-3205(82)90355-1"
"6183548","Inhibition of inflammatory pain by naloxone and its N methyl quaternary analogue","Rios L, Jacob JJ.","Life Sci. 1982 Sep 20-27;31(12-13):1209-12. doi: 10.1016/0024-3205(82)90344-7.","Rios L","Life Sci","1982","1982/09/20","","","10.1016/0024-3205(82)90344-7"
"6181247","Operation of long-range substituent effects in rigid opiates: protonated and unprotonated oxymorphone","Darling SD, Kolb VM, Mandel GS, Mandel NS.","J Pharm Sci. 1982 Jul;71(7):763-7. doi: 10.1002/jps.2600710711.","Darling SD","J Pharm Sci","1982","1982/07/01","","","10.1002/jps.2600710711"
"6176696","Irreversible opiate agonists and antagonists: the 14-hydroxydihydromorphinone azines","Hahn EF, Carroll-Buatti M, Pasternak GW.","J Neurosci. 1982 May;2(5):572-6. doi: 10.1523/JNEUROSCI.02-05-00572.1982.","Hahn EF","J Neurosci","1982","1982/05/01","PMC6564265","","10.1523/JNEUROSCI.02-05-00572.1982"
"6176227","Increased biological activity of dimers of oxymorphone and enkephalin: possible role of receptor crosslinking","Hazum E, Chang KJ, Leighton HJ, Lever OW Jr, Cuatrecasas P.","Biochem Biophys Res Commun. 1982 Jan 15;104(1):347-53. doi: 10.1016/0006-291x(82)91981-7.","Hazum E","Biochem Biophys Res Commun","1982","1982/01/15","","","10.1016/0006-291x(82)91981-7"
"6173906","Furosemide, Patella vulgata beta-glucuronidase and drug analysis: conditions for enhancement of the TLC detection of apomorphine, butorphanol, hydromorphone, nalbuphine, oxymorphone and pentazocine in equine urine","Combie J, Blake JW, Nugent TE, Tobin T.","Res Commun Chem Pathol Pharmacol. 1982 Jan;35(1):27-41.","Combie J","Res Commun Chem Pathol Pharmacol","1982","1982/01/01","","",""
"6166740","Drug--disintegrant interactions: binding of oxymorphone derivatives","Chien YW, Van Nostrand P, Hurwitz AR, Shami EG.","J Pharm Sci. 1981 Jun;70(6):709-10. doi: 10.1002/jps.2600700641.","Chien YW","J Pharm Sci","1981","1981/06/01","","","10.1002/jps.2600700641"
"6162947","Pharmacological studies with an alkylating narcotic agonist, chloroxymorphamine, and antagonist, chlornaltrexamine","Caruso TP, Larson DL, Portoghese PS, Takemori AE.","J Pharmacol Exp Ther. 1980 Jun;213(3):539-44.","Caruso TP","J Pharmacol Exp Ther","1980","1980/06/01","","",""
"6161013","Morphine analgesia after intrathecal administration of a narcotic agonist, chloroxymorphamine and antagonist, chlornaltrexamine","Larson AA, Armstrong MJ.","Eur J Pharmacol. 1980 Nov 7;68(1):25-31. doi: 10.1016/0014-2999(80)90056-4.","Larson AA","Eur J Pharmacol","1980","1980/11/07","","","10.1016/0014-2999(80)90056-4"
"6157270","[Analgesic activity of various morphine derivatives on the Afghan pika (Ochotona rufescens rufescens): tolerance of the acute effects of morphine]","Puget A.","Zentralbl Veterinarmed A. 1980 Apr;27(2):157-64.","Puget A","Zentralbl Veterinarmed A","1980","1980/04/01","","",""
"6156240","Long-acting opiate agonists and antagonists: 14-hydroxydihydromorphinone hydrazones","Pasternak GW, Hahn EF.","J Med Chem. 1980 Jun;23(6):674-6. doi: 10.1021/jm00180a019.","Pasternak GW","J Med Chem","1980","1980/06/01","","","10.1021/jm00180a019"
"6154139","Opiates and thermoregulation in mice. I. Agonists","Rosow CE, Miller JM, Pelikan EW, Cochin J.","J Pharmacol Exp Ther. 1980 May;213(2):273-83.","Rosow CE","J Pharmacol Exp Ther","1980","1980/05/01","","",""
"6145770","The peripheral narcotic antagonist N-allyl levallorphan-bromide (CM 32191) selectively prevents morphine antipropulsive action and buprenorphine in-vivo binding in the rat intestine","Bianchi G, Fiocchi R, Peracchia F, Petrillo P, Tavani A, Manara L.","J Pharm Pharmacol. 1984 May;36(5):326-30. doi: 10.1111/j.2042-7158.1984.tb04384.x.","Bianchi G","J Pharm Pharmacol","1984","1984/05/01","","","10.1111/j.2042-7158.1984.tb04384.x"
"6135996","Progress report from the NIDA Addiction Research Center (preclinical laboratory), Lexington, Kentucky","Gorodetzky CW, Cone EJ, Goldberg SR, Herling S, Risner ME, Shannon HE, Vaupel DB.","NIDA Res Monogr. 1983 Apr;43:85-91.","Gorodetzky CW","NIDA Res Monogr","1983","1983/04/01","","",""
"6119598","Evidence for a single opioid receptor type on the field stimulated rat vas deferens","Liao CS, Day AR, Freer RJ.","Life Sci. 1981 Dec 21;29(25):2617-22. doi: 10.1016/0024-3205(81)90635-4.","Liao CS","Life Sci","1981","1981/12/21","","","10.1016/0024-3205(81)90635-4"
"6103005","Estimation of high pressure liquid chromatographic retention indices of narcotic analgetics and related drugs","Baker JK, Skelton RE, Riley TN, Bagley JR.","J Chromatogr Sci. 1980 Apr;18(4):153-8. doi: 10.1093/chromsci/18.4.153.","Baker JK","J Chromatogr Sci","1980","1980/04/01","","","10.1093/chromsci/18.4.153"
"6088132","Observations on pain perception and hypertension in spontaneously hypertensive rats","Sitsen JM, de Jong W.","Clin Exp Hypertens A. 1984;6(7):1345-56. doi: 10.3109/10641968409039601.","Sitsen JM","Clin Exp Hypertens A","1984","1984/01/01","","","10.3109/10641968409039601"
"6087189","Preparation of rat brain membranes greatly enriched with either type-I-delta or type-II-delta opiate binding sites using site directed alkylating agents: evidence for a two-site allosteric model","Rothman RB, Bowen WD, Bykov V, Schumacher UK, Pert CB, Jacobson AE, Burke TR Jr, Rice KC.","Neuropeptides. 1984 May;4(3):201-15. doi: 10.1016/0143-4179(84)90101-x.","Rothman RB","Neuropeptides","1984","1984/05/01","","","10.1016/0143-4179(84)90101-x"
"6086361","Stereospecificity of 4,5-epoxymorphinan binding to the lambda site in rat brain","Yu VC, Jacobson AE, Rice KC, Sadée W.","Eur J Pharmacol. 1984 May 18;101(1-2):161-2. doi: 10.1016/0014-2999(84)90045-1.","Yu VC","Eur J Pharmacol","1984","1984/05/18","","","10.1016/0014-2999(84)90045-1"
"6084569","The effect of quaternary naloxone on the increased naloxone potency induced by morphine","Wong CL, Wai MK.","Clin Exp Pharmacol Physiol. 1984 Sep-Oct;11(5):467-71. doi: 10.1111/j.1440-1681.1984.tb00854.x.","Wong CL","Clin Exp Pharmacol Physiol","1984","1984/09/01","","","10.1111/j.1440-1681.1984.tb00854.x"
"6008043","[Antagonism of levallorphan tartrate to circulatory depression induced by oxymorphone hydrochloride]","Saito T, Matsuzaki T, Wakisaka K, Yumitate T, Okazaki K.","Masui. 1966 May;15(5):406-11.","Saito T","Masui","1966","1966/05/01","","",""
"5923211","Clinical appraisal of the narcotic antagonist N-allylnoroxymorphone","Palminteri A.","J Am Vet Med Assoc. 1966 Jun 1;148(11):1396-9.","Palminteri A","J Am Vet Med Assoc","1966","1966/06/01","","",""
"5919496","Oxymorphone re-evaluated. The addition of a respiratory antagonist","Sentnor MH, Posner NA, Kohl SG, Pomerance W.","Am J Obstet Gynecol. 1966 Oct 1;96(3):430-6.","Sentnor MH","Am J Obstet Gynecol","1966","1966/10/01","","",""
"5865529","The respiratory, circulatory, and analgesic effects of naloxone-narcotic mixtures in anaesthetized subjects","Foldes FF, Davidson GM, Duncalf D, Kuwabara S, Siker ES.","Can Anaesth Soc J. 1965 Nov;12(6):608-21. doi: 10.1007/BF03004422.","Foldes FF","Can Anaesth Soc J","1965","1965/11/01","","","10.1007/BF03004422"
"5773493","The respiratory, circulatory, and narcotic antagonistic effects of nalorphine, levallorphan, and naloxone in anaesthetized subjects","Foldes FF, Duncalf D, Kuwabara S.","Can Anaesth Soc J. 1969 Mar;16(2):151-61. doi: 10.1007/BF03005795.","Foldes FF","Can Anaesth Soc J","1969","1969/03/01","","","10.1007/BF03005795"
"5691995","[Clinical evaluation of oxymorphone in 360 cases]","Hirano T, Saito T, Wakizaka K, Okazaki K, Takatsu K.","Masui. 1968 Feb;17(2):160-5.","Hirano T","Masui","1968","1968/02/01","","",""
"5632648","[New substances usable in therapy]","","Clin Ter. 1967 May 31;41(4):391-4.","","Clin Ter","1967","1967/05/31","","",""
"5627535","[Oxymorphone anesthesia; its application to otorhinolaryngologic surgery]","Sato M.","Jibiinkoka. 1967 Oct;39(10):1125-9.","Sato M","Jibiinkoka","1967","1967/10/01","","",""
"5348430","Comparison of effect of morphine-like analgesics on transmurally stimulated guinea-pig ileum","Fennessy MR, Heimans RL, Rand MJ.","Br J Pharmacol. 1969 Oct;37(2):436-49. doi: 10.1111/j.1476-5381.1969.tb10580.x.","Fennessy MR","Br J Pharmacol","1969","1969/10/01","PMC1703699","","10.1111/j.1476-5381.1969.tb10580.x"
"5331992","Oxymorphone as an obstetric analgesic. A clinical trial","Ransom S.","Anaesthesia. 1966 Oct;21(4):464-71. doi: 10.1111/j.1365-2044.1966.tb02651.x.","Ransom S","Anaesthesia","1966","1966/10/01","","","10.1111/j.1365-2044.1966.tb02651.x"
"5315774","Effects of some narcotic analgesics upon the monosynaptic reflex inhibition from muscular and cutaneous afferents in spinal cord of the cat","Iwata N, Sakai Y.","Jpn J Pharmacol. 1971 Aug;21(4):427-37. doi: 10.1254/jjp.21.427.","Iwata N","Jpn J Pharmacol","1971","1971/08/01","","","10.1254/jjp.21.427"
"5085764","Halothane anaesthsia with premedication in dogs","Dhillon KS, Paul BS.","Indian J Physiol Pharmacol. 1972 Apr;16(2):155-8.","Dhillon KS","Indian J Physiol Pharmacol","1972","1972/04/01","","",""
"5011421","Interaction of the effects of naloxone and oxymorphone on human respiration","Kallos T, Hudson HE, Rouge JC, Smith TC.","Anesthesiology. 1972 Mar;36(3):278-85. doi: 10.1097/00000542-197203000-00016.","Kallos T","Anesthesiology","1972","1972/03/01","","","10.1097/00000542-197203000-00016"
"4846095","Opioids and obstetrics","Ricciarelli EA, Gutsche BB, Smith TC.","Clin Obstet Gynecol. 1974 Jun;17(2):259-74. doi: 10.1097/00003081-197406000-00016.","Ricciarelli EA","Clin Obstet Gynecol","1974","1974/06/01","","","10.1097/00003081-197406000-00016"
"4800174","Narcotic antagonist activity of substituted 1,2,4,5-tetrahydro-3H,3-benzazepines","Giering JE, Davidson TA, Shetty BV, Truant AP.","Adv Biochem Psychopharmacol. 1973;8(0):167-86.","Giering JE","Adv Biochem Psychopharmacol","1973","1973/01/01","","",""
"4794989","Naloxone, naltrexone, and related noroxymorphones","Blumberg H, Dayton HB.","Adv Biochem Psychopharmacol. 1973;8(0):33-43.","Blumberg H","Adv Biochem Psychopharmacol","1973","1973/01/01","","",""
"4752054","Comparison of analgesic actions of oxymorphone and morphine in rats and dogs","Dhillon KS, Paul BS.","Indian J Physiol Pharmacol. 1973 Jan-Mar;17(1):75-8.","Dhillon KS","Indian J Physiol Pharmacol","1973","1973/01/01","","",""
"4597942","Respiratory depression from alkalosis and opioid interaction in man","Hudson HE, Harber PI, Smith TC.","Anesthesiology. 1974 Jun;40(6):543-52. doi: 10.1097/00000542-197406000-00007.","Hudson HE","Anesthesiology","1974","1974/06/01","","","10.1097/00000542-197406000-00007"
"4441191","Circulatory, respiratory and antitussive effects of azidomorphine and related substances","Knoll J, Makleit S, Friedmann T, Hársing LG Jr, Hadházy P.","Arch Int Pharmacodyn Ther. 1974 Aug;210(2):241-9.","Knoll J","Arch Int Pharmacodyn Ther","1974","1974/08/01","","",""
"4186198","[Analgesics. 32]","Röthig J.","Pharm Prax. 1969;5:97-115.","Röthig J","Pharm Prax","1969","1969/01/01","","",""
"4180165","Studies of drugs given before anaesthesia. XVII: The natural and semi-synthetic opiates","Loan WB, Morrison JD, Dundee JW, Clarke RS, Hamilton RC, Brown SS.","Br J Anaesth. 1969 Jan;41(1):57-63. doi: 10.1093/bja/41.1.57.","Loan WB","Br J Anaesth","1969","1969/01/01","","","10.1093/bja/41.1.57"
"4152786","Assays for narcotic antagonist activity in rodents","Pierson AK.","Adv Biochem Psychopharmacol. 1973;8(0):245-61.","Pierson AK","Adv Biochem Psychopharmacol","1973","1973/01/01","","",""
"4149532","Analgesia during labor: effect on the fetus and neonate","Clark RB.","Clin Anesth. 1974;10(2):139-55.","Clark RB","Clin Anesth","1974","1974/01/01","","",""
"4128222","Opiate agonists and antagonists discriminated by receptor binding in brain","Pert CB, Pasternak G, Snyder SH.","Science. 1973 Dec 28;182(4119):1359-61. doi: 10.1126/science.182.4119.1359.","Pert CB","Science","1973","1973/12/28","","","10.1126/science.182.4119.1359"
"4117468","Sensitivity of thin-layer chromatography for detection of 16 opioids, cocaine and quinine","Gorodetzky CW.","Toxicol Appl Pharmacol. 1972 Nov;23(3):511-8. doi: 10.1016/0041-008x(72)90053-1.","Gorodetzky CW","Toxicol Appl Pharmacol","1972","1972/11/01","","","10.1016/0041-008x(72)90053-1"
"4007375","[Central inhibition of external pancreatic secretion by D-ala-2-metenkephalinamide in rats]","Chicau-Chovet M, Chariot J, Rozé C.","Gastroenterol Clin Biol. 1985 Mar;9(3):220-2.","Chicau-Chovet M","Gastroenterol Clin Biol","1985","1985/03/01","","",""
"3970439","Colonic motor responses in the pony: relevance of colonic stimulation by opiate antagonists","Roger T, Bardon T, Ruckebusch Y.","Am J Vet Res. 1985 Jan;46(1):31-5.","Roger T","Am J Vet Res","1985","1985/01/01","","",""
"3959755","Non-opiate and peripheral-opiate cardiovascular effects of morphine in conscious dogs","Given MB, Sander GE, Giles TD.","Life Sci. 1986 Apr 7;38(14):1299-303. doi: 10.1016/0024-3205(86)90423-6.","Given MB","Life Sci","1986","1986/04/07","","","10.1016/0024-3205(86)90423-6"
"3888579","Butorphanol","Pachter IJ, Evens RP.","Drug Alcohol Depend. 1985 Feb;14(3-4):325-38. doi: 10.1016/0376-8716(85)90065-1.","Pachter IJ","Drug Alcohol Depend","1985","1985/02/01","","","10.1016/0376-8716(85)90065-1"
"3877917","CRF-evoked bradycardia in urethane-anesthetized rats is blocked by naloxone","Kiang JG, Wei ET.","Peptides. 1985 May-Jun;6(3):409-13. doi: 10.1016/0196-9781(85)90105-6.","Kiang JG","Peptides","1985","1985/05/01","","","10.1016/0196-9781(85)90105-6"
"3841837","Interaction of adrenergic and opioid systems in the short-term regulation of cardiovascular activities","Rhee HM, Tyler L.","Can J Cardiol. 1985 Nov-Dec;1(6):395-400.","Rhee HM","Can J Cardiol","1985","1985/11/01","","",""
"3758928","Dissociation of the central and peripheral effects of naloxone on PRL secretion","Buydens P, Velkeniers B, Golstein J, Vanhaelst L.","Horm Metab Res. 1986 Aug;18(8):575-6. doi: 10.1055/s-2007-1012377.","Buydens P","Horm Metab Res","1986","1986/08/01","","","10.1055/s-2007-1012377"
"3747641","Central and peripheral inhibitory effects of morphine on intestinal transit in mice","Wong CL.","Methods Find Exp Clin Pharmacol. 1986 Aug;8(8):479-83.","Wong CL","Methods Find Exp Clin Pharmacol","1986","1986/08/01","","",""
"3640797","The use and availability of rectal narcotics","Rogers AG.","J Pain Symptom Manage. 1986 Fall;1(4):229-30. doi: 10.1016/s0885-3924(86)80046-x.","Rogers AG","J Pain Symptom Manage","1986","1986/01/01","","","10.1016/s0885-3924(86)80046-x"
"3565799","Sudden intraoperative hypotension in a patient with asymptomatic urticaria pigmentosa","Hosking MP, Warner MA.","Anesth Analg. 1987 Apr;66(4):344-6.","Hosking MP","Anesth Analg","1987","1987/04/01","","",""
"3223660","Effects of various sedatives on air cystometry in dogs","Johnson CA, Beemsterboer JM, Gray PR, Slusser PG, Goullaud EL.","Am J Vet Res. 1988 Sep;49(9):1525-8.","Johnson CA","Am J Vet Res","1988","1988/09/01","","",""
"2993609","Stereostructure-activity relationship of opioid agonist and antagonist bivalent ligands. Evidence for bridging between vicinal opioid receptors","Portoghese PS, Larson DL, Yim CB, Sayre LM, Ronsisvalle G, Lipkowski AW, Takemori AE, Rice KC, Tam SW.","J Med Chem. 1985 Sep;28(9):1140-1. doi: 10.1021/jm00147a002.","Portoghese PS","J Med Chem","1985","1985/09/01","","","10.1021/jm00147a002"
"2989428","Effects of 5,5'-dithiobis-(2-nitrobenzoic acid) on opiate binding to both the membrane-bound receptor and the partially purified opiate receptor","Nozaki M, Cho TM.","J Neurochem. 1985 Aug;45(2):461-4. doi: 10.1111/j.1471-4159.1985.tb04010.x.","Nozaki M","J Neurochem","1985","1985/08/01","","","10.1111/j.1471-4159.1985.tb04010.x"
"2884907","Effect of acepromazine, diazepam, fentanyl-droperidol, and oxymorphone on gastroesophageal sphincter pressure in healthy dogs","Hall JA, Magne ML, Twedt DC.","Am J Vet Res. 1987 Apr;48(4):556-7.","Hall JA","Am J Vet Res","1987","1987/04/01","","",""
"2861170","Differentiation of multiple analgesic opiate receptors","Fürst S, Knoll J.","Int J Tissue React. 1985;7(1):69-77.","Fürst S","Int J Tissue React","1985","1985/01/01","","",""
"2855884","Azidomorphines and heterogenous opiate receptors","Fürst S, Wagner TA, Knoll J.","Pol J Pharmacol Pharm. 1988 Nov-Dec;40(6):627-34.","Fürst S","Pol J Pharmacol Pharm","1988","1988/11/01","","",""
"2835700","Tritiated-6-beta-fluoro-6-desoxy-oxymorphone ([3H]FOXY): a new ligand and photoaffinity probe for the mu opioid receptors","Rothman RB, Bykov V, Rice KC, Jacobson AE, Kooper GN, Bowen WD.","Neuropeptides. 1988 Jan;11(1):1-6. doi: 10.1016/0143-4179(88)90020-0.","Rothman RB","Neuropeptides","1988","1988/01/01","","","10.1016/0143-4179(88)90020-0"
"2834009","Peripheral opiate receptors are not involved in the naloxone-sensitive cardiovascular effects of clonidine in rats","Mosqueda-Garcia R, Kunos G.","Brain Res. 1988 Feb 23;442(1):119-23. doi: 10.1016/0006-8993(88)91438-2.","Mosqueda-Garcia R","Brain Res","1988","1988/02/23","","","10.1016/0006-8993(88)91438-2"
"2831515","Autoradiographic evidence for two classes of mu opioid binding sites in rat brain using [125I]FK33824","Rothman RB, Jacobson AE, Rice KC, Herkenham M.","Peptides. 1987 Nov-Dec;8(6):1015-21. doi: 10.1016/0196-9781(87)90130-6.","Rothman RB","Peptides","1987","1987/11/01","","","10.1016/0196-9781(87)90130-6"
"2582304","Chloroacryloyl amides and alpha-methylenelactones from naltrexone, oxymorphone and fentanyl","Archer S, Michael J, Michael M, Simon EJ, Abdelhamid EM, Nelson WL, Koolpe GA.","Neuropeptides. 1985 Feb;5(4-6):395-8. doi: 10.1016/0143-4179(85)90037-x.","Archer S","Neuropeptides","1985","1985/02/01","","","10.1016/0143-4179(85)90037-x"
"2579319","A quantitative study of [3H]D-Ala2-D-Leu5-enkephalin binding to rat brain membranes. Evidence that oxymorphone is a noncompetitive inhibitor of the lower affinity delta-binding site","Rothman RB, Bowen WD, Herkenham M, Jacobson AE, Rice KC, Pert CB.","Mol Pharmacol. 1985 Mar;27(3):399-409.","Rothman RB","Mol Pharmacol","1985","1985/03/01","","",""
"2578752","Comparison of histamine release in human skin mast cells induced by morphine, fentanyl, and oxymorphone","Hermens JM, Ebertz JM, Hanifin JM, Hirshman CA.","Anesthesiology. 1985 Feb;62(2):124-9. doi: 10.1097/00000542-198502000-00005.","Hermens JM","Anesthesiology","1985","1985/02/01","","","10.1097/00000542-198502000-00005"
"2561142","Central and peripheral opiate receptors appear to be activated during controlled haemorrhagic hypotension","van Giersbergen PL, Cox-van Put J, de Jong W.","J Hypertens Suppl. 1989 Dec;7(6):S26-7. doi: 10.1097/00004872-198900076-00010.","van Giersbergen PL","J Hypertens Suppl","1989","1989/12/01","","","10.1097/00004872-198900076-00010"
"2551535","Opiate receptor inhibition improves the blunted baroreflex function in conscious dogs with right-sided congestive heart failure","Sakamoto S, Liang CS.","Circulation. 1989 Oct;80(4):1010-5. doi: 10.1161/01.cir.80.4.1010.","Sakamoto S","Circulation","1989","1989/10/01","","","10.1161/01.cir.80.4.1010"
"2548531","Effects of opiate antagonists and their quaternary analogues on nucleus accumbens self-stimulation","Trujillo KA, Belluzzi JD, Stein L.","Behav Brain Res. 1989 Jun 1;33(2):181-8. doi: 10.1016/s0166-4328(89)80049-x.","Trujillo KA","Behav Brain Res","1989","1989/06/01","","","10.1016/s0166-4328(89)80049-x"
"2483328","A comparison of oxymorphone and fentanyl as narcotic supplements in general anesthesia","Sinatra RS, Harrison DM.","J Clin Anesth. 1989;1(4):253-8. doi: 10.1016/0952-8180(89)90022-6.","Sinatra RS","J Clin Anesth","1989","1989/01/01","","","10.1016/0952-8180(89)90022-6"
"2482683","Naloxone reversal of oxymorphone effects in dogs","Copland VS, Haskins SC, Patz J.","Am J Vet Res. 1989 Nov;50(11):1854-8.","Copland VS","Am J Vet Res","1989","1989/11/01","","",""
"2478049","An evaluation of morphine and oxymorphone administered via patient-controlled analgesia (PCA) or PCA plus basal infusion in postcesarean-delivery patients","Sinatra R, Chung KS, Silverman DG, Brull SJ, Chung J, Harrison DM, Donielson D, Weinstock A.","Anesthesiology. 1989 Oct;71(4):502-7. doi: 10.1097/00000542-198910000-00005.","Sinatra R","Anesthesiology","1989","1989/10/01","","","10.1097/00000542-198910000-00005"
"2478048","Outpatient premedication: use of midazolam and opioid analgesics","Shafer A, White PF, Urquhart ML, Doze VA.","Anesthesiology. 1989 Oct;71(4):495-501.","Shafer A","Anesthesiology","1989","1989/10/01","","",""
"2477864","A spirohydantoin derivative of oxymorphone: an agonist with delayed antagonist activity","Alexander GJ, Chatterjie N, Wisniewski HM.","Pharmacol Biochem Behav. 1989 Apr;32(4):939-43. doi: 10.1016/0091-3057(89)90062-2.","Alexander GJ","Pharmacol Biochem Behav","1989","1989/04/01","","","10.1016/0091-3057(89)90062-2"
"2475628","Opioid agonist and antagonist activities of peripherally selective derivatives of naltrexamine and oxymorphamine","Botros S, Lipkowski AW, Larson DL, Stark PA, Takemori AE, Portoghese PS.","J Med Chem. 1989 Sep;32(9):2068-71. doi: 10.1021/jm00129a009.","Botros S","J Med Chem","1989","1989/09/01","","","10.1021/jm00129a009"
"2475287","Oxymorphone in patient-controlled analgesia","Sinatra RS, Harrison DM.","Clin Pharm. 1989 Aug;8(8):541, 544.","Sinatra RS","Clin Pharm","1989","1989/08/01","","",""
"2472540","Effects of oxymorphazone in frogs: long lasting antinociception in vivo, and apparently irreversible binding in vitro","Benyhe S, Hoffmann G, Varga E, Hosztafi S, Toth G, Borsodi A, Wollemann M.","Life Sci. 1989;44(24):1847-57. doi: 10.1016/0024-3205(89)90302-0.","Benyhe S","Life Sci","1989","1989/01/01","","","10.1016/0024-3205(89)90302-0"
"2467588","A comparison of morphine, meperidine, and oxymorphone as utilized in patient-controlled analgesia following cesarean delivery","Sinatra RS, Lodge K, Sibert K, Chung KS, Chung JH, Parker A Jr, Harrison DM.","Anesthesiology. 1989 Apr;70(4):585-90. doi: 10.1097/00000542-198904000-00005.","Sinatra RS","Anesthesiology","1989","1989/04/01","","","10.1097/00000542-198904000-00005"
"2463060","Aversive properties of opiate receptor blockade: evidence for exclusively central mediation in naive and morphine-dependent rats","Hand TH, Koob GF, Stinus L, Le Moal M.","Brain Res. 1988 Dec 6;474(2):364-8. doi: 10.1016/0006-8993(88)90452-0.","Hand TH","Brain Res","1988","1988/12/06","","","10.1016/0006-8993(88)90452-0"
"2461130","Comparison of histamine release induced by morphine and oxymorphone administration in dogs","Robinson EP, Faggella AM, Henry DP, Russell WL.","Am J Vet Res. 1988 Oct;49(10):1699-701.","Robinson EP","Am J Vet Res","1988","1988/10/01","","",""
"2452249","Irreversible opiate agonists and antagonists. IV. Analgesic actions of 14-hydroxydihydromorphinone hydrazones","Williams CL, Bodnar RJ, Clark JE, Hahn EF, Burks TF, Pasternak GW.","J Pharmacol Exp Ther. 1988 Apr;245(1):8-12.","Williams CL","J Pharmacol Exp Ther","1988","1988/04/01","","",""
"2451699","When all oral opioids cause nausea and vomiting","Rogers AG.","J Pain Symptom Manage. 1988 Spring;3(2):114. doi: 10.1016/0885-3924(88)90170-4.","Rogers AG","J Pain Symptom Manage","1988","1988/01/01","","","10.1016/0885-3924(88)90170-4"
"2451454","Delayed postoperative respiratory depression associated with oxymorphone","Patt RB.","Anesth Analg. 1988 Apr;67(4):403-4.","Patt RB","Anesth Analg","1988","1988/04/01","","",""
"2449102","Oxymorphone: cardiovascular, pulmonary, and behavioral effects in dogs","Copland VS, Haskins SC, Patz JD.","Am J Vet Res. 1987 Nov;48(11):1626-30.","Copland VS","Am J Vet Res","1987","1987/11/01","","",""
"2448633","Effects of opioid analgesics on local cerebral glucose utilization","London E, Fanelli R, Szikszay M, Jasinski D.","NIDA Res Monogr. 1986;75:379-81.","London E","NIDA Res Monogr","1986","1986/01/01","","",""
"2448626","Preparation of [3H]-oxymorphazone and its binding to rat brain membranes","Borsodi A, Varga E, Toth G, Hosztafi S.","NIDA Res Monogr. 1986;75:220-3.","Borsodi A","NIDA Res Monogr","1986","1986/01/01","","",""
"2445439","Differential effects of mu and kappa opioid analgesics on cerebral glucose utilization in the rat","Fanelli RJ, Szikszay M, Jasinski DR, London ED.","Brain Res. 1987 Oct 6;422(2):257-66. doi: 10.1016/0006-8993(87)90932-2.","Fanelli RJ","Brain Res","1987","1987/10/06","","","10.1016/0006-8993(87)90932-2"
"2444704","Hybrid bivalent ligands with opiate and enkephalin pharmacophores","Portoghese PS, Larson DL, Ronsisvalle G, Schiller PW, Nguyen TM, Lemieux C, Takemori AE.","J Med Chem. 1987 Nov;30(11):1991-4. doi: 10.1021/jm00394a010.","Portoghese PS","J Med Chem","1987","1987/11/01","","","10.1021/jm00394a010"
"2441221","Oxymorphone-naltrexonazine, a mixed opiate agonist-antagonist","Galetta S, Hahn EF, Nishimura S, Pasternak GW.","Life Sci. 1987 Aug 10;41(6):783-7. doi: 10.1016/0024-3205(87)90459-0.","Galetta S","Life Sci","1987","1987/08/10","","","10.1016/0024-3205(87)90459-0"
"2436019","Synthesis and binding of 3H-oxymorphazone to rat brain membranes","Varga E, Toth G, Benyhe S, Hosztafi S, Borsodi A.","Life Sci. 1987 Apr 20;40(16):1579-88. doi: 10.1016/0024-3205(87)90123-8.","Varga E","Life Sci","1987","1987/04/20","","","10.1016/0024-3205(87)90123-8"
"2435750","Electrochemical determination of oxymorphone in rat plasma by ion-pair reversed-phase high-performance liquid chromatography","Lam G, Williams RM, Whitney CC.","J Chromatogr. 1987 Jan 23;413:309-14. doi: 10.1016/0378-4347(87)80245-1.","Lam G","J Chromatogr","1987","1987/01/23","","","10.1016/0378-4347(87)80245-1"
"2428428","Antagonism of stress-induced analgesia by quaternary naloxone","Chance WT, Nelson JL.","Brain Res. 1986 Aug 20;380(2):394-6. doi: 10.1016/0006-8993(86)90243-x.","Chance WT","Brain Res","1986","1986/08/20","","","10.1016/0006-8993(86)90243-x"
"2423236","I.v. infusion of opioids for cancer pain: clinical review and guidelines for use","Portenoy RK, Moulin DE, Rogers A, Inturrisi CE, Foley KM.","Cancer Treat Rep. 1986 May;70(5):575-81.","Portenoy RK","Cancer Treat Rep","1986","1986/05/01","","",""
"2420241","Pulmonary function in dogs after intercostal thoracotomy: comparison of morphine, oxymorphone, and selective intercostal nerve block","Berg RJ, Orton EC.","Am J Vet Res. 1986 Feb;47(2):471-4.","Berg RJ","Am J Vet Res","1986","1986/02/01","","",""
"2419770","Agonist-antagonist properties of fluorescent opioid probes in the guinea-pig myenteric plexus-longitudinal muscle preparation","Koman A, Einarsson M, Terenius L.","Naunyn Schmiedebergs Arch Pharmacol. 1985 Dec;331(4):355-8. doi: 10.1007/BF00500819.","Koman A","Naunyn Schmiedebergs Arch Pharmacol","1985","1985/12/01","","","10.1007/BF00500819"
"2417263","Social conflict analgesia: studies on naloxone antagonism and morphine cross-tolerance in male DBA/2 mice","Rodgers RJ, Randall JI.","Pharmacol Biochem Behav. 1985 Nov;23(5):883-7. doi: 10.1016/0091-3057(85)90087-5.","Rodgers RJ","Pharmacol Biochem Behav","1985","1985/11/01","","","10.1016/0091-3057(85)90087-5"
"2416910","Irreversible opiate agonists and antagonists. III. Phenylhydrazone derivatives of naloxone and oxymorphone","Hahn EF, Itzhak Y, Nishimura S, Johnson N, Pasternak GW.","J Pharmacol Exp Ther. 1985 Dec;235(3):846-50.","Hahn EF","J Pharmacol Exp Ther","1985","1985/12/01","","",""
"2416909","Irreversible opiate agonists and antagonists. II. Evidence against a bivalent mechanism of action for opiate azines and diacylhydrazones","Hahn EF, Nishimura S, Goodman RR, Pasternak GW.","J Pharmacol Exp Ther. 1985 Dec;235(3):839-45.","Hahn EF","J Pharmacol Exp Ther","1985","1985/12/01","","",""
"2415705","Opioid receptor interactions and conformations of the 6 alpha and 6 beta epimers of oxymorphamine. Solid-state conformation of 6 alpha-oxymorphamine","Lever OW Jr, Bhatia AV, Chang KJ.","J Med Chem. 1985 Nov;28(11):1652-6. doi: 10.1021/jm00149a019.","Lever OW Jr","J Med Chem","1985","1985/11/01","","","10.1021/jm00149a019"
"2409281","10-Ketonaltrexone and 10-ketooxymorphone","Archer S, Seyed-Mozaffari A, Ward S, Kosterlitz HW, Paterson SJ, McKnight AT, Corbett AD.","J Med Chem. 1985 Jul;28(7):974-6. doi: 10.1021/jm00145a024.","Archer S","J Med Chem","1985","1985/07/01","","","10.1021/jm00145a024"
"2409280","Opioid agonists and antagonists. 6-Desoxy-6-substituted lactone, epoxide, and glycidate ester derivatives of naltrexone and oxymorphone","Koolpe GA, Nelson WL, Gioannini TL, Angel L, Appelmans N, Simon EJ.","J Med Chem. 1985 Jul;28(7):949-57. doi: 10.1021/jm00145a018.","Koolpe GA","J Med Chem","1985","1985/07/01","","","10.1021/jm00145a018"
"2272347","Neurohypophyseal hormones and excessive grooming behaviour","Van Wimersma Greidanus TB, Kroodsma JM, Pot ML, Stevens M, Maigret C.","Eur J Pharmacol. 1990 Oct 2;187(1):1-8. doi: 10.1016/0014-2999(90)90334-3.","Van Wimersma Greidanus TB","Eur J Pharmacol","1990","1990/10/02","","","10.1016/0014-2999(90)90334-3"
"2228767","Effects of sedation on intradermal skin testing in flea-allergic dogs","Beale KM, Kunkle GA, Chalker L, Cannon R.","J Am Vet Med Assoc. 1990 Oct 1;197(7):861-4.","Beale KM","J Am Vet Med Assoc","1990","1990/10/01","","",""
"2219678","Reversal of oxymorphone sedation by naloxone, nalmefene, and butorphanol","Dyson DH, Doherty T, Anderson GI, McDonell WN.","Vet Surg. 1990 Sep-Oct;19(5):398-403. doi: 10.1111/j.1532-950x.1990.tb01217.x.","Dyson DH","Vet Surg","1990","1990/09/01","","","10.1111/j.1532-950x.1990.tb01217.x"
"2154800","5-Methylated naloxone, naltrexone, oxymorphone, and their 14-O-methyl ethers","Schmidhammer H, Leander JD, Mayer-Valkanover K, Nussbaumer C, Schmidt C, Schoepp DD, Schratz A, Walla-Kugler M.","Prog Clin Biol Res. 1990;328:41-4.","Schmidhammer H","Prog Clin Biol Res","1990","1990/01/01","","",""
"2135030","Subcutaneous-PCA: an alternative to IV-PCA for postoperative pain management","White PF.","Clin J Pain. 1990 Dec;6(4):297-300.","White PF","Clin J Pain","1990","1990/12/01","","",""
"2079653","Transdermal oxymorphone formulation development and methods for evaluating flux and lag times for two skin permeation-enhancing vehicles","Aungst BJ, Blake JA, Rogers NJ, Hussain MA.","J Pharm Sci. 1990 Dec;79(12):1072-6. doi: 10.1002/jps.2600791207.","Aungst BJ","J Pharm Sci","1990","1990/12/01","","","10.1002/jps.2600791207"
"2030304","Adult dosage of opioid analgesic in a four-year-old with gastritis","Rogers AG.","J Pain Symptom Manage. 1991 May;6(4):270-1. doi: 10.1016/0885-3924(91)90019-z.","Rogers AG","J Pain Symptom Manage","1991","1991/05/01","","","10.1016/0885-3924(91)90019-z"
"2020013","Gastric acid secretion in Basenji dogs with immunoproliferative enteropathy","Breitschwerdt EB, MacLachlan NJ, Argenzio RA, Hurlbert SA, Babineau C, De Buysscher EV.","J Vet Intern Med. 1991 Jan-Feb;5(1):34-9. doi: 10.1111/j.1939-1676.1991.tb00928.x.","Breitschwerdt EB","J Vet Intern Med","1991","1991/01/01","","","10.1111/j.1939-1676.1991.tb00928.x"
"1980878","Central versus peripheral opioid regulation of ingestive behavior in the domestic fowl","Denbow DM, McCormack JF.","Comp Biochem Physiol C. 1990;96(1):211-6. doi: 10.1016/0742-8413(90)90070-p.","Denbow DM","Comp Biochem Physiol C","1990","1990/01/01","","","10.1016/0742-8413(90)90070-p"
"1963479","Pretreatment of rats with the irreversible mu-receptor antagonist, beta-FNA, fails to prevent naltrexone-induced upregulation of mu-opioid receptors","Rothman RB, Long JB, Bykov V, Jacobson AE, Rice KC, Holaday JW.","Neuropharmacology. 1990 Sep;29(9):805-10. doi: 10.1016/0028-3908(90)90153-i.","Rothman RB","Neuropharmacology","1990","1990/09/01","","","10.1016/0028-3908(90)90153-i"
"1963452","Mouse paw oedema induced by Habu snake (Trimeresurus flavoviridis) venom: inhibition by morphine, naloxone and methylnaloxone alone or in combinations","Detrait J, Jacob J.","Jpn J Exp Med. 1990 Aug;60(4):187-96.","Detrait J","Jpn J Exp Med","1990","1990/08/01","","",""
"1958450","The pharmacokinetics of oxycodone after intravenous injection in adults","Pöyhiä R, Olkkola KT, Seppälä T, Kalso E.","Br J Clin Pharmacol. 1991 Oct;32(4):516-8. doi: 10.1111/j.1365-2125.1991.tb03942.x.","Pöyhiä R","Br J Clin Pharmacol","1991","1991/10/01","PMC1368617","","10.1111/j.1365-2125.1991.tb03942.x"
"1810807","Evidence for peripheral mechanisms mediating the antitussive actions of opioids in the guinea pig","Callaway JK, King RG, Boura AL.","Gen Pharmacol. 1991;22(6):1103-8. doi: 10.1016/0306-3623(91)90585-t.","Callaway JK","Gen Pharmacol","1991","1991/01/01","","","10.1016/0306-3623(91)90585-t"
"1723353","Endogenous opioid peptides and blood pressure regulation during controlled, stepwise hemorrhagic hypotension","van den Berg MH, van Giersbergen PL, Cox-van Put J, de Jong W.","Circ Shock. 1991 Oct;35(2):102-8.","van den Berg MH","Circ Shock","1991","1991/10/01","","",""
"1718477","Narcotic-induced histamine release: a comparison of morphine, oxymorphone, and fentanyl infusions","Warner MA, Hosking MP, Gray JR, Squillace DL, Yunginger JW, Orszulak TA.","J Cardiothorac Vasc Anesth. 1991 Oct;5(5):481-4. doi: 10.1016/1053-0770(91)90123-b.","Warner MA","J Cardiothorac Vasc Anesth","1991","1991/10/01","","","10.1016/1053-0770(91)90123-b"
"1698268","Quaternary naloxone blocks morphine analgesia in spinal but not intact rats","Milne RJ, Coddington JM, Gamble GD.","Neurosci Lett. 1990 Jul 13;114(3):259-64. doi: 10.1016/0304-3940(90)90573-r.","Milne RJ","Neurosci Lett","1990","1990/07/13","","","10.1016/0304-3940(90)90573-r"
"1680708","Pharmacological assessment of the site of action of opioids on the release of vasopressin and oxytocin in the rat","Van de Heijning BJ, Koekkoek-Van den Herik I, Maigret C, Van Wimersma Greidanus TB.","Eur J Pharmacol. 1991 May 17;197(2-3):175-80. doi: 10.1016/0014-2999(91)90518-u.","Van de Heijning BJ","Eur J Pharmacol","1991","1991/05/17","","","10.1016/0014-2999(91)90518-u"
"1675119","Epidural analgesia during and after cesarean delivery. Comparison of five opioids","Celleno D, Capogna G, Sebastiani M, Costantino P, Muratori F, Cipriani G, Emanuelli M.","Reg Anesth. 1991 Mar-Apr;16(2):79-83.","Celleno D","Reg Anesth","1991","1991/03/01","","",""
"1639702","Cardiopulmonary and behavioral effects of combinations of acepromazine/butorphanol and acepromazine/oxymorphone in dogs","Cornick JL, Hartsfield SM.","J Am Vet Med Assoc. 1992 Jun 15;200(12):1952-6.","Cornick JL","J Am Vet Med Assoc","1992","1992/06/15","","",""
"1510312","Analgesia and behavioral responses of dogs given oxymorphone-acepromazine and meperidine-acepromazine after methoxyflurane and halothane anesthesia","Sawyer DC, Rech RH, Adams T, Durham RA, Richter MA, Striler EL.","Am J Vet Res. 1992 Aug;53(8):1361-8.","Sawyer DC","Am J Vet Res","1992","1992/08/01","","",""
"1483894","Narcotics, miosis, and cataract surgery","Kaswan RL, Quandt JE, Moore PA.","J Am Vet Med Assoc. 1992 Dec 15;201(12):1819-20.","Kaswan RL","J Am Vet Med Assoc","1992","1992/12/15","","",""
"1429259","A comparison of anesthetic agents and their effects on the response properties of the peripheral auditory system","Dodd F, Capranica RR.","Hear Res. 1992 Oct;62(2):173-80. doi: 10.1016/0378-5955(92)90183-n.","Dodd F","Hear Res","1992","1992/10/01","","","10.1016/0378-5955(92)90183-n"
"1413474","A clinical comparison of oxymorphone-acepromazine and butorphanol-acepromazine sedation in dogs","Dyson DH, Atilola M.","Vet Surg. 1992 Sep-Oct;21(5):418-21. doi: 10.1111/j.1532-950x.1992.tb01720.x.","Dyson DH","Vet Surg","1992","1992/09/01","","","10.1111/j.1532-950x.1992.tb01720.x"
"1413473","Cardiovascular and pulmonary effects of atropine reversal of oxymorphone-induced bradycardia in dogs","Copland VS, Haskins SC, Patz JD.","Vet Surg. 1992 Sep-Oct;21(5):414-7. doi: 10.1111/j.1532-950x.1992.tb01719.x.","Copland VS","Vet Surg","1992","1992/09/01","","","10.1111/j.1532-950x.1992.tb01719.x"
"1408307","Differential antinociceptive effects of morphine and methylmorphine in the formalin test","Oluyomi AO, Hart SL, Smith TW.","Pain. 1992 Jun;49(3):415-8. doi: 10.1016/0304-3959(92)90249-b.","Oluyomi AO","Pain","1992","1992/06/01","","","10.1016/0304-3959(92)90249-b"
"1389934","The pharmacokinetics and metabolism of oxycodone after intramuscular and oral administration to healthy subjects","Pöyhiä R, Seppälä T, Olkkola KT, Kalso E.","Br J Clin Pharmacol. 1992 Jun;33(6):617-21. doi: 10.1111/j.1365-2125.1992.tb04090.x.","Pöyhiä R","Br J Clin Pharmacol","1992","1992/06/01","PMC1381353","","10.1111/j.1365-2125.1992.tb04090.x"
"1369531","Epidural vs. intramuscular oxymorphone analgesia after thoracotomy in dogs","Popilskis S, Kohn D, Sanchez JA, Gorman P.","Vet Surg. 1991 Nov-Dec;20(6):462-7. doi: 10.1111/j.1532-950x.1991.tb00356.x.","Popilskis S","Vet Surg","1991","1991/11/01","","","10.1111/j.1532-950x.1991.tb00356.x"
"1335078","O3-(2-carbomethoxyallyl) ethers of opioid ligands derived from oxymorphone, naltrexone, etorphine, diprenorphine, norbinaltorphimine, and naltrindole. Unexpected O3-dealkylation in the opioid radioligand displacement assay","Klein P, Nelson WL.","J Med Chem. 1992 Nov 27;35(24):4589-94. doi: 10.1021/jm00102a012.","Klein P","J Med Chem","1992","1992/11/27","","","10.1021/jm00102a012"
"1317041","Inhibitory effect of opiates on male rat sexual behavior may be mediated by opiate receptors outside the central nervous system","Agmo A, Rojas J, Vázquez P.","Psychopharmacology (Berl). 1992;107(1):89-96. doi: 10.1007/BF02244971.","Agmo A","Psychopharmacology (Berl)","1992","1992/01/01","","","10.1007/BF02244971"
"1309468","Opioid agonists binding and responses in SH-SY5Y cells","Costa EM, Hoffmann BB, Loew GH.","Life Sci. 1992;50(1):73-81. doi: 10.1016/0024-3205(92)90199-y.","Costa EM","Life Sci","1992","1992/01/01","","","10.1016/0024-3205(92)90199-y"
"1169188","[Radioimmunoassay of drugs capable of inducing dependency]","Takahashi M, Koide M, Kaneto H.","Nihon Yakurigaku Zasshi. 1975 Mar;71(2):123-9.","Takahashi M","Nihon Yakurigaku Zasshi","1975","1975/03/01","","",""
"1012443","Enhancement of reflexes by naloxone in spinal cats","Goldfarb J, Hu JW.","Neuropharmacology. 1976 Dec;15(12):785-92. doi: 10.1016/0028-3908(76)90009-5.","Goldfarb J","Neuropharmacology","1976","1976/12/01","","","10.1016/0028-3908(76)90009-5"
"966967","Morphine: ability to block neuronal activity evoked by a nociceptive stimulus","Haigler HJ.","Life Sci. 1976 Sep 15;19(6):841-57. doi: 10.1016/0024-3205(76)90312-x.","Haigler HJ","Life Sci","1976","1976/09/15","","","10.1016/0024-3205(76)90312-x"
"717878","Cardiopulmonary effects of narcotic agonists and a partial agonist in horses","Muir WW, Skarda RT, Sheehan WC.","Am J Vet Res. 1978 Oct;39(10):1632-5.","Muir WW","Am J Vet Res","1978","1978/10/01","","",""
"685073","Narcotic analgesics in the domestic cat","Penney BE, White RJ.","Vet Clin North Am. 1978 May;8(2):317-24. doi: 10.1016/s0091-0279(78)50037-3.","Penney BE","Vet Clin North Am","1978","1978/05/01","","","10.1016/s0091-0279(78)50037-3"
"647163","Inhibition by morphine of prostaglandin-stimulated fluid secretion in rat jejunum","Coupar IM.","Br J Pharmacol. 1978 May;63(1):57-63. doi: 10.1111/j.1476-5381.1978.tb07774.x.","Coupar IM","Br J Pharmacol","1978","1978/05/01","PMC1668301","","10.1111/j.1476-5381.1978.tb07774.x"
"525911","Objective tests of analgesic drugs in ponies","Pippi NL, Lumb WV.","Am J Vet Res. 1979 Aug;40(8):1082-6.","Pippi NL","Am J Vet Res","1979","1979/08/01","","",""
"237112","Oxilorphan (l-N-cyclopropylmethyl-3,14-dihydroxymorphinan): a new synthetic narcotic antagonist","Pircio AW, Gylys JA.","J Pharmacol Exp Ther. 1975 Apr;193(1):23-34.","Pircio AW","J Pharmacol Exp Ther","1975","1975/04/01","","",""
"237084","The pharmacology of 14-hydroxyazidomorphine","Knoll J, Fürst S, Makleit S.","J Pharm Pharmacol. 1975 Feb;27(2):99-105. doi: 10.1111/j.2042-7158.1975.tb09416.x.","Knoll J","J Pharm Pharmacol","1975","1975/02/01","","","10.1111/j.2042-7158.1975.tb09416.x"
"213725","Structure-activity studies of narcotic agonists and antagonists from quantum chemical calculations","Loew GH, Berkowitz DS, Burt SK.","NIDA Res Monogr. 1978;(22):278-316.","Loew GH","NIDA Res Monogr","1978","1978/01/01","","",""
"207856","New opiate-receptor model","Kolb VM.","J Pharm Sci. 1978 Jul;67(7):999-1002. doi: 10.1002/jps.2600670735.","Kolb VM","J Pharm Sci","1978","1978/07/01","","","10.1002/jps.2600670735"
"185469","Exploration of drug action on a morphine receptor by methods of enzyme kinetics","Gero A, Capetola RJ.","J Theor Biol. 1976 Sep 7;61(1):129-42. doi: 10.1016/0022-5193(76)90109-0.","Gero A","J Theor Biol","1976","1976/09/07","","","10.1016/0022-5193(76)90109-0"
"86208","Chloroxymorphamine, and opioid receptor site-directed alkylating agent having narcotic agonist activity","Caruso TP, Takemori AE, Larson DL, Portoghese PS.","Science. 1979 Apr 20;204(4390):316-8. doi: 10.1126/science.86208.","Caruso TP","Science","1979","1979/04/20","","","10.1126/science.86208"
"83655","10-oxomorphine, a decomposition product of morphine","Proksa B, Votický Z, Molnár L, Putek J, Stefek M.","Pharmazie. 1978 Sep;33(9):609.","Proksa B","Pharmazie","1978","1978/09/01","","",""
"83167","The biology of social attachments: opiates alleviate separation distress","Panksepp J, Herman B, Conner R, Bishop P, Scott JP.","Biol Psychiatry. 1978 Oct;13(5):607-18.","Panksepp J","Biol Psychiatry","1978","1978/10/01","","",""
"74199","Azidomorphines and homopyrimidazols: a new approach to the ideal analgetic","Knoll J.","Acta Physiol Pharmacol Bulg. 1977;3(2):3-11.","Knoll J","Acta Physiol Pharmacol Bulg","1977","1977/01/01","","",""
"73588","Quantum chemical studies of N-substituent variation in the oxymorphone series of opiate narcotics","Loew GH, Berkowitz DS.","J Med Chem. 1978 Jan;21(1):101-6. doi: 10.1021/jm00199a018.","Loew GH","J Med Chem","1978","1978/01/01","","","10.1021/jm00199a018"
"69027","Diastereoisomeric N-tetrahydrofurfurylnoroxymorphones with opioid agonist--antagonist properties","Merz H, Stockhaus K, Wick H.","J Med Chem. 1977 Jun;20(6):844-6. doi: 10.1021/jm00216a023.","Merz H","J Med Chem","1977","1977/06/01","","","10.1021/jm00216a023"
"67128","A comparison of the analgesic effect of oxymorphone by rectal suppository and intramuscular injection in patients with postoperative pain","Beaver WT, Feise GA.","J Clin Pharmacol. 1977 May-Jun;17(5-6):276-91. doi: 10.1002/j.1552-4604.1977.tb04607.x.","Beaver WT","J Clin Pharmacol","1977","1977/05/01","","","10.1002/j.1552-4604.1977.tb04607.x"
"66306","Orientation of the oxygen atom at C-6 as a determinant of agonistic activity in the oxymorphone series","Ronai AZ, Foldes FF, Hahn EF, Fishman J.","J Pharmacol Exp Ther. 1977 Mar;200(3):496-500.","Ronai AZ","J Pharmacol Exp Ther","1977","1977/03/01","","",""
"66240","Comparisons of the analgesic effects of oral and intramuscular oxymorphone and of intramuscular oxymorphone and morphine in patients with cancer","Beaver WT, Wallenstein SL, Houde RW, Rogers A.","J Clin Pharmacol. 1977 Apr;17(4):186-98. doi: 10.1177/009127007701700402.","Beaver WT","J Clin Pharmacol","1977","1977/04/01","","","10.1177/009127007701700402"
"60089","The pharmacology of butorphanol, a 3,14-dihydroxymorphinan narcotic antagonist analgesic","Pircio AW, Gylys JA, Cavanagh RL, Buyniski JP, Bierwagen ME.","Arch Int Pharmacodyn Ther. 1976 Apr;220(2):231-57.","Pircio AW","Arch Int Pharmacodyn Ther","1976","1976/04/01","","",""
"48348","Combination of delta9-tetrahydrocannabinol with oxymorphone or pentobarbital: Effects on ventilatory control and cardiovascular dynamics","Johnstone RE, Lief PL, Kulp RA, Smith TC.","Anesthesiology. 1975 Jun;42(6):674-84. doi: 10.1097/00000542-197506000-00009.","Johnstone RE","Anesthesiology","1975","1975/06/01","","","10.1097/00000542-197506000-00009"
"46111","Differentiation of opiate agonist and antagonist receptor binding by protein modifying reagents","Wilson HA, Pasternak GW, Snyder SH.","Nature. 1975 Feb 6;253(5491):448-50. doi: 10.1038/253448a0.","Wilson HA","Nature","1975","1975/02/06","","","10.1038/253448a0"
"16134","5-allyl-9-oxobenzomorphans. 3. Potent narcotic antagonists and analgesics-antagonists in the series of substituted 2',9beta-dihydroxy-6,7-benzomorphans","Saucier M, Daris JP, Lambert Y, Monkovié, pircio AW.","J Med Chem. 1977 May;20(5):676-82. doi: 10.1021/jm00215a012.","Saucier M","J Med Chem","1977","1977/05/01","","","10.1021/jm00215a012"
